- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01035255
Questo studio valuterà l'efficacia e la sicurezza di LCZ696 rispetto a Enalapril sulla morbilità e mortalità dei pazienti con insufficienza cardiaca cronica (PARADIGM-HF)
13 luglio 2016 aggiornato da: Novartis Pharmaceuticals
Uno studio multicentrico, randomizzato, in doppio cieco, a gruppi paralleli, con controllo attivo per valutare l'efficacia e la sicurezza di LCZ696 rispetto a Enalapril su morbilità e mortalità in pazienti con insufficienza cardiaca cronica e frazione di eiezione ridotta
Lo studio valuterà l'efficacia e la sicurezza di LCZ696 rispetto all'enalapril su morbilità e mortalità in pazienti con insufficienza cardiaca cronica (classe NYHA II - IV e FE = < 35%).
Panoramica dello studio
Stato
Terminato
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Effettivo)
8442
Fase
- Fase 3
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Buenos Aires, Argentina
- Novartis Investigative Site
-
Buenos Aires, Argentina, C1405BCH
- Novartis Investigative Site
-
Buenos Aires, Argentina, C1090AAH
- Novartis Investigative Site
-
Buenos Aires, Argentina, C1209ABD
- Novartis Investigative Site
-
Buenos Aires, Argentina, C1426EGR
- Novartis Investigative Site
-
Cordoba, Argentina, X5016KEH
- Novartis Investigative Site
-
Cordoba, Argentina, X5003DCP
- Novartis Investigative Site
-
Cordoba, Argentina, X5009BSN
- Novartis Investigative Site
-
Cordoba, Argentina, X5000AAW
- Novartis Investigative Site
-
Cordoba, Argentina, X5016KET
- Novartis Investigative Site
-
Cordoba, Argentina, 5000
- Novartis Investigative Site
-
Cordoba, Argentina, X5000AAX
- Novartis Investigative Site
-
Cordoba, Argentina, X5000BSQ
- Novartis Investigative Site
-
Cordoba, Argentina, X5014OPO
- Novartis Investigative Site
-
Corrientes, Argentina, W3400
- Novartis Investigative Site
-
Corrientes, Argentina, W3400CLH
- Novartis Investigative Site
-
Córdoba, Argentina, X5006IKK
- Novartis Investigative Site
-
Formosa, Argentina, P3600
- Novartis Investigative Site
-
Formosa, Argentina, P3634XAR
- Novartis Investigative Site
-
Mendoza, Argentina, M5500CHC
- Novartis Investigative Site
-
Mendoza, Argentina, M5500AAJ
- Novartis Investigative Site
-
Mendoza, Argentina, M5500EOB
- Novartis Investigative Site
-
Salta, Argentina, A4400ANG
- Novartis Investigative Site
-
San Juan, Argentina, J5402DIL
- Novartis Investigative Site
-
San Luis, Argentina, D5702JRS
- Novartis Investigative Site
-
Santa Fe, Argentina, S3000FWO
- Novartis Investigative Site
-
Santa Fe, Argentina, S3000EOZ
- Novartis Investigative Site
-
Santiago del Estero, Argentina, G4200AQK
- Novartis Investigative Site
-
-
Buenos Aires
-
Caba, Buenos Aires, Argentina, C1221ADC
- Novartis Investigative Site
-
Caba, Buenos Aires, Argentina, C1425DTG
- Novartis Investigative Site
-
Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1119ACN
- Novartis Investigative Site
-
Lanus, Buenos Aires, Argentina, B1824ABE
- Novartis Investigative Site
-
Mar del Plata, Buenos Aires, Argentina, B7600FZN
- Novartis Investigative Site
-
Mar del Plata, Buenos Aires, Argentina, B7600DHK
- Novartis Investigative Site
-
Mar del Plata, Buenos Aires, Argentina, B7600FZD
- Novartis Investigative Site
-
Munro, Buenos Aires, Argentina, B1605DSX
- Novartis Investigative Site
-
Pilar, Buenos Aires, Argentina, B1629AHJ
- Novartis Investigative Site
-
Quilmes, Buenos Aires, Argentina, B1878DVB
- Novartis Investigative Site
-
San Isidro, Buenos Aires, Argentina, B1642DJG
- Novartis Investigative Site
-
Zarate, Buenos Aires, Argentina, 2800
- Novartis Investigative Site
-
-
Capital Federal
-
Caba, Capital Federal, Argentina, C1179AAB
- Novartis Investigative Site
-
Caba, Capital Federal, Argentina, C1425FVH
- Novartis Investigative Site
-
-
Chubut
-
Trelew, Chubut, Argentina, U9100AQR
- Novartis Investigative Site
-
-
Jujuy
-
San Salvador de Jujuy, Jujuy, Argentina, Y4600ABF
- Novartis Investigative Site
-
-
Rio Negro
-
Cipolletti, Rio Negro, Argentina, 8324
- Novartis Investigative Site
-
-
San Juan
-
Buenos Aires, San Juan, Argentina
- Novartis Investigative Site
-
-
Santa Fe
-
Rosario, Santa Fe, Argentina, S2000AII
- Novartis Investigative Site
-
Rosario, Santa Fe, Argentina, S200CXP
- Novartis Investigative Site
-
Rosario, Santa Fe, Argentina, 2000
- Novartis Investigative Site
-
Rosario, Santa Fe, Argentina, S2002KDS
- Novartis Investigative Site
-
Rosario, Santa Fe, Argentina, S2001SBL
- Novartis Investigative Site
-
-
Tucuman
-
San Miguel de Tucuman, Tucuman, Argentina, T4000EBR
- Novartis Investigative Site
-
San Miguel de Tucuman, Tucuman, Argentina, T4000JCU
- Novartis Investigative Site
-
San Miguel de Tucuman, Tucuman, Argentina, T4000IIH
- Novartis Investigative Site
-
-
-
-
-
Antwerpen, Belgio, 2060
- Novartis Investigative Site
-
Baudour, Belgio, 7331
- Novartis Investigative Site
-
Bonheiden, Belgio, 2820
- Novartis Investigative Site
-
Brasschaat, Belgio, 2930
- Novartis Investigative Site
-
Brugge, Belgio, 8000
- Novartis Investigative Site
-
Brussel, Belgio, 1090
- Novartis Investigative Site
-
Brussels, Belgio, 1070
- Novartis Investigative Site
-
Gent, Belgio, 9000
- Novartis Investigative Site
-
Hasselt, Belgio, 3500
- Novartis Investigative Site
-
Heusden-Zolder, Belgio, 3550
- Novartis Investigative Site
-
La Louvière, Belgio, 7100
- Novartis Investigative Site
-
Leuven, Belgio, 3000
- Novartis Investigative Site
-
Ottignies, Belgio, 1340
- Novartis Investigative Site
-
Ronse, Belgio, 9600
- Novartis Investigative Site
-
-
-
-
BA
-
Salvador, BA, Brasile, 41810-010
- Novartis Investigative Site
-
Salvador, BA, Brasile, 40140-110
- Novartis Investigative Site
-
-
DF
-
Brasilia, DF, Brasile, 70390-903
- Novartis Investigative Site
-
-
GO
-
Goiania, GO, Brasile, 74223-130
- Novartis Investigative Site
-
Goiania, GO, Brasile, 74605-050
- Novartis Investigative Site
-
Goiania, GO, Brasile, 74823-470
- Novartis Investigative Site
-
-
MA
-
Sao Luis, MA, Brasile, 65020-070
- Novartis Investigative Site
-
-
MG
-
Belo Horizonte, MG, Brasile, 30150-221
- Novartis Investigative Site
-
Belo Horizonte, MG, Brasile, 20180-090
- Novartis Investigative Site
-
Uberlândia, MG, Brasile, 38400-368
- Novartis Investigative Site
-
-
PA
-
Belem, PA, Brasile, 66087-660
- Novartis Investigative Site
-
-
PE
-
Recife, PE, Brasile, 50100-030
- Novartis Investigative Site
-
Recife, PE, Brasile, 50100-130
- Novartis Investigative Site
-
Recife, PE, Brasile, 52051 - 38
- Novartis Investigative Site
-
-
PR
-
Curitiba, PR, Brasile, 80730-150
- Novartis Investigative Site
-
-
RJ
-
Rio de Janeiro, RJ, Brasile, 21941-590
- Novartis Investigative Site
-
Rio de Janeiro, RJ, Brasile, 22280-020
- Novartis Investigative Site
-
Rio de Janeiro, RJ, Brasile, 22261-010
- Novartis Investigative Site
-
-
RN
-
Natal, RN, Brasile, 59020-035
- Novartis Investigative Site
-
-
RS
-
Passo Fundo, RS, Brasile, 99010-080
- Novartis Investigative Site
-
Porto Alegre, RS, Brasile, 90880-480
- Novartis Investigative Site
-
Porto Alegre, RS, Brasile, 90620-001
- Novartis Investigative Site
-
Porto Alegre, RS, Brasile, 92425900
- Novartis Investigative Site
-
-
SP
-
Marilia, SP, Brasile, 17515-000
- Novartis Investigative Site
-
Ribeirao Preto, SP, Brasile, 14055-370
- Novartis Investigative Site
-
Santo Andre, SP, Brasile, 09190-615
- Novartis Investigative Site
-
Santo Andre, SP, Brasile, 09030-640
- Novartis Investigative Site
-
Sao Jose do Rio Preto, SP, Brasile, 15015-750
- Novartis Investigative Site
-
Sao Paulo, SP, Brasile, 01327-010
- Novartis Investigative Site
-
São Paulo, SP, Brasile, 05403-000
- Novartis Investigative Site
-
São Paulo, SP, Brasile, 01506-000
- Novartis Investigative Site
-
Votuporanga, SP, Brasile, 15500-003
- Novartis Investigative Site
-
-
-
-
-
Burgas, Bulgaria, 8000
- Novartis Investigative Site
-
Haskovo, Bulgaria, 6300
- Novartis Investigative Site
-
Pazardzhik, Bulgaria, 4400
- Novartis Investigative Site
-
Pleven, Bulgaria, 5800
- Novartis Investigative Site
-
Plovdiv, Bulgaria, 4002
- Novartis Investigative Site
-
Plovdiv, Bulgaria, 4000
- Novartis Investigative Site
-
Plovdiv, Bulgaria, 4004
- Novartis Investigative Site
-
Russe, Bulgaria, 7002
- Novartis Investigative Site
-
Shumen, Bulgaria, 9700
- Novartis Investigative Site
-
Silistra, Bulgaria, 7500
- Novartis Investigative Site
-
Sofia, Bulgaria, 1527
- Novartis Investigative Site
-
Sofia, Bulgaria, 1309
- Novartis Investigative Site
-
Sofia, Bulgaria, 1431
- Novartis Investigative Site
-
Sofia, Bulgaria, 1202
- Novartis Investigative Site
-
Sofia, Bulgaria, 1233
- Novartis Investigative Site
-
Sofia, Bulgaria, 1606
- Novartis Investigative Site
-
Sofia, Bulgaria, 1505
- Novartis Investigative Site
-
Stara Zagora, Bulgaria, 6000
- Novartis Investigative Site
-
Varna, Bulgaria, 9010
- Novartis Investigative Site
-
Veliko Tarnovo, Bulgaria, 5000
- Novartis Investigative Site
-
-
-
-
British Columbia
-
New Westminster, British Columbia, Canada, V3L 3W4
- Novartis Investigative Site
-
Surrey, British Columbia, Canada, V3V 1N1
- Novartis Investigative Site
-
Victoria, British Columbia, Canada, V8R4R2
- Novartis Investigative Site
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1G 1A7
- Novartis Investigative Site
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 2Y9
- Novartis Investigative Site
-
-
Ontario
-
Cambridge, Ontario, Canada, N1R 6V6
- Novartis Investigative Site
-
Kitchener, Ontario, Canada, N2M 5N4
- Novartis Investigative Site
-
London, Ontario, Canada, N6A 5A5
- Novartis Investigative Site
-
Oshawa, Ontario, Canada, L1J 2K1
- Novartis Investigative Site
-
Sudbury, Ontario, Canada, P3E 3B8
- Novartis Investigative Site
-
Toronto, Ontario, Canada, M5G 2N2
- Novartis Investigative Site
-
Toronto, Ontario, Canada, M5B 1W8
- Novartis Investigative Site
-
Toronto, Ontario, Canada, M5G 1X5
- Novartis Investigative Site
-
Weston, Ontario, Canada, M9N 1W4
- Novartis Investigative Site
-
-
Quebec
-
Granby, Quebec, Canada, J2G 1T7
- Novartis Investigative Site
-
Lachine, Quebec, Canada, H8S 2E4
- Novartis Investigative Site
-
Laval, Quebec, Canada, H7M 3L9
- Novartis Investigative Site
-
Longueuil, Quebec, Canada, J4M 2X1
- Novartis Investigative Site
-
Lévis, Quebec, Canada, G6V 4Z5
- Novartis Investigative Site
-
Montreal, Quebec, Canada, H2W 1T8
- Novartis Investigative Site
-
Montreal, Quebec, Canada, H3T 1E2
- Novartis Investigative Site
-
Montreal, Quebec, Canada, H3G 1A4
- Novartis Investigative Site
-
Montreal, Quebec, Canada, H3A 1A1
- Novartis Investigative Site
-
Sainte-Foy, Quebec, Canada, G1V 4G5
- Novartis Investigative Site
-
Sherbrooke, Quebec, Canada, J1G-2E8
- Novartis Investigative Site
-
St-Georges Beauce, Quebec, Canada, G5Y 4T8
- Novartis Investigative Site
-
Thetford Mines, Quebec, Canada, G6G 2V4
- Novartis Investigative Site
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4P 0w5
- Novartis Investigative Site
-
-
-
-
-
Santiago, Chile
- Novartis Investigative Site
-
Santiago, Chile, 8360160
- Novartis Investigative Site
-
Talcahuano, Chile
- Novartis Investigative Site
-
-
Araucania
-
Temuco, Araucania, Chile, 4780000
- Novartis Investigative Site
-
-
Bio Bio
-
Los Angeles, Bio Bio, Chile, 4440000
- Novartis Investigative Site
-
-
Cautin
-
Temuco, Cautin, Chile
- Novartis Investigative Site
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile
- Novartis Investigative Site
-
-
Santiago
-
San Miguel, Santiago, Chile, 8900000
- Novartis Investigative Site
-
Vitacura, Santiago, Chile, 7630000
- Novartis Investigative Site
-
-
-
-
-
Baotou, Cina, 014040
- Novartis Investigative Site
-
Beijing, Cina, 100044
- Novartis Investigative Site
-
Beijing, Cina, 100730
- Novartis Investigative Site
-
Beijing, Cina, 100029
- Novartis Investigative Site
-
Chongqing, Cina, 400037
- Novartis Investigative Site
-
Shanghai, Cina, 200080
- Novartis Investigative Site
-
-
Beijing
-
Beijing, Beijing, Cina, 100037
- Novartis Investigative Site
-
-
Heilongjiang
-
Harbin, Heilongjiang, Cina, 150001
- Novartis Investigative Site
-
-
Hunan
-
Changsha, Hunan, Cina, 410003
- Novartis Investigative Site
-
-
Jiangsu
-
Nanjing, Jiangsu, Cina, 210029
- Novartis Investigative Site
-
Nanjing, Jiangsu, Cina
- Novartis Investigative Site
-
Nanjing, Jiangsu, Cina, 210009
- Novartis Investigative Site
-
-
Liaoning
-
Shenyang, Liaoning, Cina, 110003
- Novartis Investigative Site
-
-
Shanxi
-
Xi'an, Shanxi, Cina, 710061
- Novartis Investigative Site
-
-
Sichuan
-
Chengdu, Sichuan, Cina, 610041
- Novartis Investigative Site
-
-
Zhejiang
-
Hangzhou, Zhejiang, Cina, 310009
- Novartis Investigative Site
-
-
-
-
-
Barranquilla, Colombia
- Novartis Investigative Site
-
Bogotá, Colombia
- Novartis Investigative Site
-
Cali, Colombia
- Novartis Investigative Site
-
Cartegena, Colombia
- Novartis Investigative Site
-
Florida Blanca, Colombia
- Novartis Investigative Site
-
Medellín, Colombia
- Novartis Investigative Site
-
-
Atlantico
-
Barranquilla, Atlantico, Colombia
- Novartis Investigative Site
-
-
Bolivar
-
Cartagena, Bolivar, Colombia
- Novartis Investigative Site
-
-
Cundinamarca
-
Bogota, Cundinamarca, Colombia, 0000
- Novartis Investigative Site
-
-
Santander
-
Bucaramanga, Santander, Colombia
- Novartis Investigative Site
-
Floridablanca, Santander, Colombia, 57-7
- Novartis Investigative Site
-
-
-
-
-
Busan, Corea, Repubblica di, 602-739
- Novartis Investigative Site
-
Daegu, Corea, Repubblica di, 705-703
- Novartis Investigative Site
-
Daegu, Corea, Repubblica di, 705-718
- Novartis Investigative Site
-
Gwangju, Corea, Repubblica di, 501-757
- Novartis Investigative Site
-
Pusan, Corea, Repubblica di, 614-735
- Novartis Investigative Site
-
Seoul, Corea, Repubblica di, 156-707
- Novartis Investigative Site
-
Seoul, Corea, Repubblica di, 110-102
- Novartis Investigative Site
-
Seoul, Corea, Repubblica di, 134-701
- Novartis Investigative Site
-
-
Gangwon-Do
-
Wonju, Gangwon-Do, Corea, Repubblica di, 220-701
- Novartis Investigative Site
-
-
Gyeonggi-do
-
Suwon, Gyeonggi-do, Corea, Repubblica di, 443-380
- Novartis Investigative Site
-
-
Korea
-
Seoul, Korea, Corea, Repubblica di, 137-701
- Novartis Investigative Site
-
Seoul, Korea, Corea, Repubblica di, 120-752
- Novartis Investigative Site
-
Seoul, Korea, Corea, Repubblica di, 138-736
- Novartis Investigative Site
-
-
-
-
-
Aarhus C, Danimarca, DK-8000
- Novartis Investigative Site
-
Copenhagen, Danimarca, DK-2100
- Novartis Investigative Site
-
Esbjerg, Danimarca, DK-6700
- Novartis Investigative Site
-
Hellerup, Danimarca, DK-2900
- Novartis Investigative Site
-
Herning, Danimarca, DK-7400
- Novartis Investigative Site
-
Randers NØ, Danimarca, DK-8930
- Novartis Investigative Site
-
Roskilde, Danimarca, DK-4000
- Novartis Investigative Site
-
Svendborg, Danimarca, DK-5700
- Novartis Investigative Site
-
Vejle, Danimarca, DK-7100
- Novartis Investigative Site
-
Viborg, Danimarca, DK-8800
- Novartis Investigative Site
-
-
-
-
Guayas
-
Guayaquil, Guayas, Ecuador, 412
- Novartis Investigative Site
-
Guayaquil, Guayas, Ecuador
- Novartis Investigative Site
-
Guayaquil, Guayas, Ecuador, 559
- Novartis Investigative Site
-
-
Pichincha
-
Quito, Pichincha, Ecuador, 1701
- Novartis Investigative Site
-
-
-
-
-
Haabneeme, Viimsi vald, Estonia, 74001
- Novartis Investigative Site
-
Tallinn, Estonia, 13419
- Novartis Investigative Site
-
Tallinn, Estonia, 10138
- Novartis Investigative Site
-
Tartu, Estonia, 50410
- Novartis Investigative Site
-
-
-
-
-
Ekaterinburg, Federazione Russa, 620028
- Novartis Investigative Site
-
Ekaterinburg, Federazione Russa, 620102
- Novartis Investigative Site
-
Ekaterinburg, Federazione Russa, 620137
- Novartis Investigative Site
-
Gatchina, Federazione Russa, 188300
- Novartis Investigative Site
-
Ivanovo, Federazione Russa, 153012
- Novartis Investigative Site
-
Izhevsk, Federazione Russa, 426063
- Novartis Investigative Site
-
Kazan, Federazione Russa, 420012
- Novartis Investigative Site
-
Kemerovo, Federazione Russa, 650002
- Novartis Investigative Site
-
Kemerovo, Federazione Russa, 650029
- Novartis Investigative Site
-
Kemerovo, Federazione Russa, 650099
- Novartis Investigative Site
-
Kirov, Federazione Russa, 610027
- Novartis Investigative Site
-
Krasnodar, Federazione Russa, 350086
- Novartis Investigative Site
-
Krasnodar, Federazione Russa, 350012
- Novartis Investigative Site
-
Moscow, Federazione Russa, 125284
- Novartis Investigative Site
-
Moscow, Federazione Russa, 117198
- Novartis Investigative Site
-
Moscow, Federazione Russa, 105229
- Novartis Investigative Site
-
Moscow, Federazione Russa, 119333
- Novartis Investigative Site
-
Moscow, Federazione Russa, 119992
- Novartis Investigative Site
-
Moscow, Federazione Russa, 127473
- Novartis Investigative Site
-
Moscow, Federazione Russa, 115516
- Novartis Investigative Site
-
Moscow, Federazione Russa, 121552
- Novartis Investigative Site
-
Moscow, Federazione Russa, 117556
- Novartis Investigative Site
-
Moscow, Federazione Russa, 121309
- Novartis Investigative Site
-
Moscow, Federazione Russa, 101990
- Novartis Investigative Site
-
Moscow, Federazione Russa, 115280
- Novartis Investigative Site
-
Moscow, Federazione Russa, 119881
- Novartis Investigative Site
-
Moscow, Federazione Russa, 111539
- Novartis Investigative Site
-
Moscow, Federazione Russa, 109240
- Novartis Investigative Site
-
Moscow, Federazione Russa, 105203
- Novartis Investigative Site
-
Moscow, Federazione Russa, 115487
- Novartis Investigative Site
-
N. Novgorod, Federazione Russa, 603003
- Novartis Investigative Site
-
N.Novgorod, Federazione Russa, 603005
- Novartis Investigative Site
-
N.Novgorod, Federazione Russa, 603073
- Novartis Investigative Site
-
Nizhnii Novgorod, Federazione Russa, 603126
- Novartis Investigative Site
-
Novosibirsk, Federazione Russa, 630087
- Novartis Investigative Site
-
Novosibirsk, Federazione Russa, 630051
- Novartis Investigative Site
-
Novosibirsk-117, Federazione Russa, 630117
- Novartis Investigative Site
-
Orenburg, Federazione Russa, 460000
- Novartis Investigative Site
-
Orenburg, Federazione Russa, 460040
- Novartis Investigative Site
-
Penza, Federazione Russa, 440026
- Novartis Investigative Site
-
Perm, Federazione Russa, 614097
- Novartis Investigative Site
-
Petrozavodsk, Federazione Russa, 185019
- Novartis Investigative Site
-
Rostov-on-Don, Federazione Russa, 344022
- Novartis Investigative Site
-
S-Petersburg, Federazione Russa, 191144
- Novartis Investigative Site
-
S.-Petersburg, Federazione Russa, 198205
- Novartis Investigative Site
-
S.-Petersburg, Federazione Russa, 194354
- Novartis Investigative Site
-
Saint Petersburg, Federazione Russa, 199106
- Novartis Investigative Site
-
Saint Petersburg, Federazione Russa, 195067
- Novartis Investigative Site
-
Saint-Petersburg, Federazione Russa, 194044
- Novartis Investigative Site
-
Saint-Petersburg, Federazione Russa, 197341
- Novartis Investigative Site
-
Samara, Federazione Russa, 443070
- Novartis Investigative Site
-
Samara, Federazione Russa, 443095
- Novartis Investigative Site
-
Sankt-Peterburg, Federazione Russa, 197022
- Novartis Investigative Site
-
Saratov, Federazione Russa, 410028
- Novartis Investigative Site
-
Saratov, Federazione Russa, 410012
- Novartis Investigative Site
-
Smolensk, Federazione Russa, 214018
- Novartis Investigative Site
-
St-Peterburg, Federazione Russa, 190000
- Novartis Investigative Site
-
St-Petersburg, Federazione Russa, 194017
- Novartis Investigative Site
-
St-Petersburg, Federazione Russa, 194295
- Novartis Investigative Site
-
St-Petersburg, Federazione Russa, 196084
- Novartis Investigative Site
-
St-Petersburg, Federazione Russa, 197119
- Novartis Investigative Site
-
St. Petersburg, Federazione Russa, 198013
- Novartis Investigative Site
-
St.Petersburg, Federazione Russa, 193163
- Novartis Investigative Site
-
Syktyvkar, Federazione Russa, 167981
- Novartis Investigative Site
-
Tula, Federazione Russa, 300053
- Novartis Investigative Site
-
Tver, Federazione Russa, 170036
- Novartis Investigative Site
-
Vladimir, Federazione Russa, 600020
- Novartis Investigative Site
-
Volgograd, Federazione Russa, 400008
- Novartis Investigative Site
-
Voronezh, Federazione Russa, 394065
- Novartis Investigative Site
-
Yaroslavl, Federazione Russa, 150003
- Novartis Investigative Site
-
Yaroslavl, Federazione Russa, 150062
- Novartis Investigative Site
-
-
-
-
-
Bulacan, Filippine, 3020
- Novartis Investigative Site
-
Manila, Filippine
- Novartis Investigative Site
-
Manila, Filippine, 1000
- Novartis Investigative Site
-
Manila, Filippine, 1003
- Novartis Investigative Site
-
Pasig City, Filippine, 1605
- Novartis Investigative Site
-
Quezon City, Filippine, 1102
- Novartis Investigative Site
-
Quezon City, Filippine, 1100
- Novartis Investigative Site
-
San Juan City, Filippine, 1500
- Novartis Investigative Site
-
-
Batangas
-
Lipa City, Batangas, Filippine, 4217
- Novartis Investigative Site
-
-
Manila
-
Quezon City, Manila, Filippine, 1100
- Novartis Investigative Site
-
-
Metro Manila
-
Quezon City, Metro Manila, Filippine, 1109
- Novartis Investigative Site
-
-
-
-
-
HUS, Finlandia, 00029
- Novartis Investigative Site
-
Kemi, Finlandia, FIN-94100
- Novartis Investigative Site
-
Kuopio, Finlandia, 70100
- Novartis Investigative Site
-
Oulu, Finlandia, 90100
- Novartis Investigative Site
-
Tampere, Finlandia, 33521
- Novartis Investigative Site
-
-
-
-
-
Abbeville, Francia, 80100
- Novartis Investigative Site
-
Bayonne, Francia, 64100
- Novartis Investigative Site
-
Bayonne, Francia, 64109
- Novartis Investigative Site
-
Beziers Cedex, Francia, 34525
- Novartis Investigative Site
-
Bordeaux Cedex, Francia, 33075
- Novartis Investigative Site
-
Caen, Francia, 14000
- Novartis Investigative Site
-
Cholet, Francia, 49325
- Novartis Investigative Site
-
Creteil, Francia, 94010
- Novartis Investigative Site
-
Essey Les Nancy, Francia, 54270
- Novartis Investigative Site
-
Grenoble, Francia, 38043
- Novartis Investigative Site
-
Lagny sur Marne, Francia, 77405
- Novartis Investigative Site
-
Langres, Francia, 52206
- Novartis Investigative Site
-
Le Chesnay, Francia
- Novartis Investigative Site
-
Le Plessis Robinson, Francia, 92350
- Novartis Investigative Site
-
Limoges, Francia, 87001
- Novartis Investigative Site
-
Lomme, Francia, 59462
- Novartis Investigative Site
-
Montpellier, Francia, 34195
- Novartis Investigative Site
-
Nice Cedex 1, Francia, 06602
- Novartis Investigative Site
-
Paris, Francia, 75015
- Novartis Investigative Site
-
Paris cedex 10, Francia, 75010
- Novartis Investigative Site
-
Reims, Francia, 51092
- Novartis Investigative Site
-
Rouen, Francia, 76031
- Novartis Investigative Site
-
St Aubin Lès Elbeuf, Francia, 76410
- Novartis Investigative Site
-
Toulouse Cedex, Francia, 31059
- Novartis Investigative Site
-
Tourcoing, Francia, 59208
- Novartis Investigative Site
-
Valencienne, Francia, 59322
- Novartis Investigative Site
-
Vandoeuvre les Nancy, Francia, 54511
- Novartis Investigative Site
-
-
Cedex
-
Strasbourg, Cedex, Francia, 67091
- Novartis Investigative Site
-
-
-
-
-
Ahrensfelde, Germania, 16356
- Novartis Investigative Site
-
Bad Homburg, Germania, 61348
- Novartis Investigative Site
-
Bad Krozingen, Germania, 79189
- Novartis Investigative Site
-
Bad Salzuflen, Germania, 32105
- Novartis Investigative Site
-
Bad Schwartau, Germania, 23611
- Novartis Investigative Site
-
Barsinghausen, Germania, 30890
- Novartis Investigative Site
-
Berlin, Germania, 10117
- Novartis Investigative Site
-
Berlin, Germania, 14050
- Novartis Investigative Site
-
Berlin, Germania, 10787
- Novartis Investigative Site
-
Berlin, Germania, 10789
- Novartis Investigative Site
-
Berlin, Germania, 13347
- Novartis Investigative Site
-
Berlin, Germania, 10369
- Novartis Investigative Site
-
Berlin, Germania, 10115
- Novartis Investigative Site
-
Berlin, Germania, 13055
- Novartis Investigative Site
-
Berlin, Germania, 13509
- Novartis Investigative Site
-
Berlin, Germania, 10559
- Novartis Investigative Site
-
Berlin-Buch, Germania, 13125
- Novartis Investigative Site
-
Bernau, Germania, 16321
- Novartis Investigative Site
-
Bitburg, Germania, 54634
- Novartis Investigative Site
-
Bremen, Germania, 28277
- Novartis Investigative Site
-
Chemnitz, Germania, 09130
- Novartis Investigative Site
-
Darmstadt, Germania, 64287
- Novartis Investigative Site
-
Dessau-Roßlau, Germania, 06846
- Novartis Investigative Site
-
Dietzenbach, Germania, 63128
- Novartis Investigative Site
-
Dortmund, Germania, 44137
- Novartis Investigative Site
-
Dresden, Germania, 01309
- Novartis Investigative Site
-
Dresden, Germania, 01127
- Novartis Investigative Site
-
Dresden, Germania, 01129
- Novartis Investigative Site
-
Dresden, Germania, 01099
- Novartis Investigative Site
-
Eilenburg, Germania, 04838
- Novartis Investigative Site
-
Elsterwerda, Germania, 04910
- Novartis Investigative Site
-
Erfurt, Germania, 99084
- Novartis Investigative Site
-
Frankfurt, Germania, 65929
- Novartis Investigative Site
-
Frankfurt, Germania, 60488
- Novartis Investigative Site
-
Georgsmarienhütte, Germania, 49124
- Novartis Investigative Site
-
Giengen, Germania, 89537
- Novartis Investigative Site
-
Goch, Germania, 47574
- Novartis Investigative Site
-
Graben-Neudorf, Germania, 76676
- Novartis Investigative Site
-
Hamburg, Germania, 21075
- Novartis Investigative Site
-
Hamburg, Germania, 22041
- Novartis Investigative Site
-
Hamburg, Germania, 22291
- Novartis Investigative Site
-
Hamburg, Germania, 22765
- Novartis Investigative Site
-
Hamburg, Germania, 22527
- Novartis Investigative Site
-
Hamminkeln, Germania, 46499
- Novartis Investigative Site
-
Hannover, Germania, 30165
- Novartis Investigative Site
-
Heidelberg, Germania, 69115
- Novartis Investigative Site
-
Homburg, Germania, 66421
- Novartis Investigative Site
-
Hoppegarten-Dahlwitz, Germania, 15366
- Novartis Investigative Site
-
Huy / OT Anderbeck, Germania, 38836
- Novartis Investigative Site
-
Ingelheim, Germania, 55218
- Novartis Investigative Site
-
Jena, Germania, 07740
- Novartis Investigative Site
-
Jena, Germania, 07743
- Novartis Investigative Site
-
Kallstadt, Germania, 67169
- Novartis Investigative Site
-
Kassel, Germania, 34121
- Novartis Investigative Site
-
Kassel, Germania, 34125
- Novartis Investigative Site
-
Kassel, Germania, 34127
- Novartis Investigative Site
-
Kelkheim, Germania, 65779
- Novartis Investigative Site
-
Koethen, Germania, 06366
- Novartis Investigative Site
-
Künzelsau, Germania, 74653
- Novartis Investigative Site
-
Langen, Germania, 63225
- Novartis Investigative Site
-
Leipzig, Germania, 04357
- Novartis Investigative Site
-
Leipzig, Germania, 04103
- Novartis Investigative Site
-
Leipzig, Germania, 04109
- Novartis Investigative Site
-
Leipzig, Germania, 04129
- Novartis Investigative Site
-
Leipzig, Germania, 04315
- Novartis Investigative Site
-
Loehne, Germania, 32584
- Novartis Investigative Site
-
Ludwigshafen, Germania, 67067
- Novartis Investigative Site
-
Ludwigshafen, Germania, 67061
- Novartis Investigative Site
-
Lübeck, Germania, 23558
- Novartis Investigative Site
-
Lütjenburg, Germania, 24321
- Novartis Investigative Site
-
Mainz, Germania, 55131
- Novartis Investigative Site
-
Mainz, Germania, 55116
- Novartis Investigative Site
-
Mannheim, Germania, 68165
- Novartis Investigative Site
-
Meissen, Germania, 01662
- Novartis Investigative Site
-
Meißen, Germania, 01662
- Novartis Investigative Site
-
Muenster, Germania, 48149
- Novartis Investigative Site
-
Mönchengladbach, Germania, 41063
- Novartis Investigative Site
-
Mühldorf, Germania, 84453
- Novartis Investigative Site
-
Mühlheim, Germania, 45468
- Novartis Investigative Site
-
München, Germania, 80336
- Novartis Investigative Site
-
Münster, Germania, 48149
- Novartis Investigative Site
-
Neunkirchen, Germania, 66539
- Novartis Investigative Site
-
Neunkirchen, Germania, 57290
- Novartis Investigative Site
-
Nienburg, Germania, 31582
- Novartis Investigative Site
-
Offenbach, Germania, 63073
- Novartis Investigative Site
-
Oldenburg i.H., Germania, 23758
- Novartis Investigative Site
-
Osnabrück, Germania, 49080
- Novartis Investigative Site
-
Papenburg, Germania, 26871
- Novartis Investigative Site
-
Rhaunen, Germania, 55624
- Novartis Investigative Site
-
Riesa, Germania, 01589
- Novartis Investigative Site
-
Rodgau, Germania, 63110
- Novartis Investigative Site
-
Schenklengsfeld, Germania, 36277
- Novartis Investigative Site
-
Schkeuditz, Germania, 04435
- Novartis Investigative Site
-
Schwäbisch Hall, Germania, 74523
- Novartis Investigative Site
-
St. Ingbert - Oberwuerzbach, Germania, 66386
- Novartis Investigative Site
-
Unterschneidheim, Germania, 73485
- Novartis Investigative Site
-
Wangen, Germania, 88239
- Novartis Investigative Site
-
Wardenburg, Germania, 26203
- Novartis Investigative Site
-
Weeze, Germania, 47652
- Novartis Investigative Site
-
Wermsdorf, Germania, 04779
- Novartis Investigative Site
-
Westhofen, Germania, 67593
- Novartis Investigative Site
-
Wetzlar-Naunheim, Germania, 35584
- Novartis Investigative Site
-
Weyhe, Germania, 28844
- Novartis Investigative Site
-
Wolmirstedt, Germania, 39326
- Novartis Investigative Site
-
-
Baden-Württemberg
-
Mannheim, Baden-Württemberg, Germania, 68305
- Novartis Investigative Site
-
-
-
-
-
Guatemala City, Guatemala, 01010
- Novartis Investigative Site
-
Guatemala City, Guatemala, 01011
- Novartis Investigative Site
-
Guatemala City, Guatemala, 01015
- Novartis Investigative Site
-
-
-
-
-
Hong Kong, Hong Kong
- Novartis Investigative Site
-
Hong Kong, Hong Kong, HONG KONG
- Novartis Investigative Site
-
Hong Kong SAR, Hong Kong
- Novartis Investigative Site
-
-
-
-
-
Ahmedabad, India, 380052
- Novartis Investigative Site
-
Hyderabad, India, 500 063
- Novartis Investigative Site
-
Indore, India, 452014
- Novartis Investigative Site
-
-
Andhra Pradesh
-
Guntur, Andhra Pradesh, India, 522001
- Novartis Investigative Site
-
Hyderabad, Andhra Pradesh, India, 500012
- Novartis Investigative Site
-
Hyderabad, Andhra Pradesh, India, 500082
- Novartis Investigative Site
-
Tirupati, Andhra Pradesh, India, 517501
- Novartis Investigative Site
-
Vishakhapatnam, Andhra Pradesh, India, 530002
- Novartis Investigative Site
-
Vishakhapatnam, Andhra Pradesh, India, 530 013
- Novartis Investigative Site
-
-
Andhra Pradesh, INDIA
-
Hyderabad, Andhra Pradesh, INDIA, India, 500034
- Novartis Investigative Site
-
-
Delhi
-
Dehli, Delhi, India, 110080
- Novartis Investigative Site
-
-
Gujarat
-
Ahmedabad, Gujarat, India, 380014
- Novartis Investigative Site
-
Ahmedabad, Gujarat, India, 380 013
- Novartis Investigative Site
-
Ahmedabad, Gujarat, India, 380025
- Novartis Investigative Site
-
Anand, Gujarat, India, 388325
- Novartis Investigative Site
-
Surat, Gujarat, India, 395001
- Novartis Investigative Site
-
-
Gujrat
-
Rajkot, Gujrat, India, 360001
- Novartis Investigative Site
-
Vadodara, Gujrat, India, 390015
- Novartis Investigative Site
-
-
Haryana
-
Gurgaon, Haryana, India, 122001
- Novartis Investigative Site
-
-
Karnataka
-
Bangalore, Karnataka, India, 560038
- Novartis Investigative Site
-
Bangalore, Karnataka, India, 560092
- Novartis Investigative Site
-
Banglaore, Karnataka, India, 560054
- Novartis Investigative Site
-
Mangalore, Karnataka, India, 575002
- Novartis Investigative Site
-
Mysore, Karnataka, India, 570004
- Novartis Investigative Site
-
-
Kerala
-
Cochin, Kerala, India, 683572
- Novartis Investigative Site
-
Trivandrum, Kerala, India, 695011
- Novartis Investigative Site
-
Trivandrum, Kerala, India, 695607
- Novartis Investigative Site
-
-
Maharashtra
-
Mumbai, Maharashtra, India, 400012
- Novartis Investigative Site
-
Nagpur, Maharashtra, India, 400012
- Novartis Investigative Site
-
Nagpur, Maharashtra, India, 440 010
- Novartis Investigative Site
-
Nagpur, Maharashtra, India, 44000033
- Novartis Investigative Site
-
Nashik, Maharashtra, India, 422005
- Novartis Investigative Site
-
Nashik, Maharashtra, India, 422 005
- Novartis Investigative Site
-
Nashik, Maharashtra, India, 422002
- Novartis Investigative Site
-
Pune, Maharashtra, India, 411 011
- Novartis Investigative Site
-
Pune, Maharashtra, India, 411011
- Novartis Investigative Site
-
Pune, Maharashtra, India, 411 005
- Novartis Investigative Site
-
-
Punjab
-
Ludhiana, Punjab, India, 141002
- Novartis Investigative Site
-
-
Rajasthan
-
Bikaner, Rajasthan, India, 334003
- Novartis Investigative Site
-
Jaipur, Rajasthan, India, 302016
- Novartis Investigative Site
-
Kota, Rajasthan, India, 324005
- Novartis Investigative Site
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600004
- Novartis Investigative Site
-
Chennai, Tamil Nadu, India, 600020
- Novartis Investigative Site
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, India, 226003
- Novartis Investigative Site
-
Varanasi, Uttar Pradesh, India, 221 005
- Novartis Investigative Site
-
-
-
-
-
Kopavogur, Islanda, 201
- Novartis Investigative Site
-
Reykjavik, Islanda, IS-109
- Novartis Investigative Site
-
Reykjavik, Islanda, IS-101
- Novartis Investigative Site
-
-
-
-
-
Ashkelon, Israele, 78278
- Novartis Investigative Site
-
Hadera, Israele, 38100
- Novartis Investigative Site
-
Haifa, Israele, 31096
- Novartis Investigative Site
-
Haifa, Israele, 3436212
- Novartis Investigative Site
-
Jerusalem, Israele, 91031
- Novartis Investigative Site
-
Jerusalem, Israele, 9112001
- Novartis Investigative Site
-
Petach Tikva, Israele, 49100
- Novartis Investigative Site
-
Rehovot, Israele, 76100
- Novartis Investigative Site
-
Safed, Israele, 13100
- Novartis Investigative Site
-
-
-
-
AO
-
Aosta, AO, Italia, 11100
- Novartis Investigative Site
-
-
AR
-
Cortona, AR, Italia, 52044
- Novartis Investigative Site
-
-
BG
-
Bergamo, BG, Italia, 24128
- Novartis Investigative Site
-
Seriate, BG, Italia, 24068
- Novartis Investigative Site
-
Treviglio, BG, Italia, 24047
- Novartis Investigative Site
-
-
BR
-
San Pietro Vernotico, BR, Italia, 72027
- Novartis Investigative Site
-
-
BZ
-
Bolzano, BZ, Italia, 39100
- Novartis Investigative Site
-
-
CS
-
Cosenza, CS, Italia, 87100
- Novartis Investigative Site
-
-
CZ
-
Catanzaro, CZ, Italia, 88100
- Novartis Investigative Site
-
-
FE
-
Cona, FE, Italia, 44100
- Novartis Investigative Site
-
-
FI
-
Firenze, FI, Italia, 50143
- Novartis Investigative Site
-
-
GE
-
Genova, GE, Italia, 16132
- Novartis Investigative Site
-
-
IS
-
Pozzilli, IS, Italia, 86077
- Novartis Investigative Site
-
-
LU
-
Lido di Camaiore, LU, Italia, 55041
- Novartis Investigative Site
-
-
MB
-
Monza, MB, Italia, 20900
- Novartis Investigative Site
-
-
ME
-
Milazzo, ME, Italia, 98057
- Novartis Investigative Site
-
-
MI
-
Milano, MI, Italia, 20122
- Novartis Investigative Site
-
-
MO
-
Modena, MO, Italia, 41100
- Novartis Investigative Site
-
-
PD
-
Piove di Sacco, PD, Italia, 35028
- Novartis Investigative Site
-
-
PG
-
Perugia, PG, Italia, 06100
- Novartis Investigative Site
-
-
PI
-
Pisa, PI, Italia, 56126
- Novartis Investigative Site
-
-
PT
-
Pescia, PT, Italia, 51017
- Novartis Investigative Site
-
-
PV
-
Casorate Primo, PV, Italia, 27022
- Novartis Investigative Site
-
Pavia, PV, Italia, 27100
- Novartis Investigative Site
-
Stradella, PV, Italia, 27049
- Novartis Investigative Site
-
-
RM
-
Albano Laziale, RM, Italia, 00041
- Novartis Investigative Site
-
Roma, RM, Italia, 00163
- Novartis Investigative Site
-
-
SA
-
Battipaglia, SA, Italia, 84091
- Novartis Investigative Site
-
Cava De' Tirreni, SA, Italia, 84013
- Novartis Investigative Site
-
Salerno, SA, Italia, 84131
- Novartis Investigative Site
-
-
SS
-
Sassari, SS, Italia, 07100
- Novartis Investigative Site
-
Thiesi, SS, Italia, 07047
- Novartis Investigative Site
-
-
UD
-
Palmanova, UD, Italia, 33057
- Novartis Investigative Site
-
San Daniele Del Friuli, UD, Italia, 33038
- Novartis Investigative Site
-
-
VA
-
Tradate, VA, Italia, 21049
- Novartis Investigative Site
-
Varese, VA, Italia, 21100
- Novartis Investigative Site
-
-
VV
-
Vibo Valentia, VV, Italia, 89900
- Novartis Investigative Site
-
-
-
-
-
Daugavplis, Lettonia, LV-5417
- Novartis Investigative Site
-
Kuldiga, Lettonia, LV-3300
- Novartis Investigative Site
-
Preili, Lettonia, LV-5301
- Novartis Investigative Site
-
Riga, Lettonia, 1002
- Novartis Investigative Site
-
Ventspils, Lettonia, LV-3601
- Novartis Investigative Site
-
-
LV
-
Liepaja, LV, Lettonia, LV-3414
- Novartis Investigative Site
-
-
-
-
-
Kaunas, Lituania, LT-49387
- Novartis Investigative Site
-
Kaunas, Lituania, 50009
- Novartis Investigative Site
-
Kedainiai, Lituania, LT-57164
- Novartis Investigative Site
-
Siauliai, Lituania, LT-76231
- Novartis Investigative Site
-
Vilnius, Lituania, LT-08661
- Novartis Investigative Site
-
-
-
-
-
Kuala Lumpur, Malaysia, 59100
- Novartis Investigative Site
-
Kuala Lumpur, Malaysia, 50400
- Novartis Investigative Site
-
-
Penang
-
Pulau Pinang, Penang, Malaysia, 10990
- Novartis Investigative Site
-
-
Sarawak
-
Kuching, Sarawak, Malaysia, 94300
- Novartis Investigative Site
-
-
-
-
-
Aguascalientes, Messico, 20230
- Novartis Investigative Site
-
Queretaro, Messico, 76000
- Novartis Investigative Site
-
San Luis Potosi, Messico, 78200
- Novartis Investigative Site
-
San Luis Potosí, Messico, 78200
- Novartis Investigative Site
-
San Luis Potosí, Messico, 78240
- Novartis Investigative Site
-
-
Distrito Federal
-
Mexico, Distrito Federal, Messico, 07300
- Novartis Investigative Site
-
Mexico City, Distrito Federal, Messico, 06700
- Novartis Investigative Site
-
Mexico D.F, Distrito Federal, Messico, 03100
- Novartis Investigative Site
-
México, Distrito Federal, Messico, 06720
- Novartis Investigative Site
-
-
Jalisco
-
Guadalajara, Jalisco, Messico, 44280
- Novartis Investigative Site
-
Zapopan, Jalisco, Messico, 45200
- Novartis Investigative Site
-
-
Nuevo León
-
Monterrey, Nuevo León, Messico, 64710
- Novartis Investigative Site
-
-
Queretaro
-
San Juan del Rio, Queretaro, Messico, 76800
- Novartis Investigative Site
-
-
-
-
-
Amersfoort, Olanda, 3813 TZ
- Novartis Investigative Site
-
Arnhem, Olanda, 6815 AD
- Novartis Investigative Site
-
Blaricum, Olanda, 1261 AN
- Novartis Investigative Site
-
Breda, Olanda, 4818 CK
- Novartis Investigative Site
-
Delft, Olanda, 2625 AD
- Novartis Investigative Site
-
Den Bosch, Olanda, 5223 GZ
- Novartis Investigative Site
-
Den Haag, Olanda, 2512 VA
- Novartis Investigative Site
-
Ede, Olanda, 6716 RP
- Novartis Investigative Site
-
Eindhoven, Olanda, 5623 EJ
- Novartis Investigative Site
-
Goes, Olanda, 4462 RA
- Novartis Investigative Site
-
Gorinchem, Olanda, 4204 AA
- Novartis Investigative Site
-
Hardenberg, Olanda, 7770 AA
- Novartis Investigative Site
-
Harderwijk, Olanda, 3840 AC
- Novartis Investigative Site
-
Heerenveen, Olanda, 8441 PW
- Novartis Investigative Site
-
Hengelo, Olanda, 7555 DL
- Novartis Investigative Site
-
Hoorn, Olanda, 1625 HV
- Novartis Investigative Site
-
Maastricht, Olanda, 6229 HX
- Novartis Investigative Site
-
Nijmegen, Olanda, 6525 GA
- Novartis Investigative Site
-
Sneek, Olanda, 8601 ZK
- Novartis Investigative Site
-
Tilburg, Olanda, 5022 GC
- Novartis Investigative Site
-
Veldhoven, Olanda, 5504 DB
- Novartis Investigative Site
-
-
NL
-
Oss, NL, Olanda, 5342 BT
- Novartis Investigative Site
-
-
-
-
Panamá
-
Panama City, Panamá, Panama
- Novartis Investigative Site
-
Panama City, Panamá, Panama, 0831-02351
- Novartis Investigative Site
-
-
-
-
-
Arequipa, Perù, Areq01
- Novartis Investigative Site
-
-
Lima
-
Bellavista, Lima, Perù, CALLAO 02
- Novartis Investigative Site
-
Cercado de Lima, Lima, Perù, 01
- Novartis Investigative Site
-
Jesus Maria, Lima, Perù, 11
- Novartis Investigative Site
-
La Molina, Lima, Perù, 12
- Novartis Investigative Site
-
San Borja, Lima, Perù, 41
- Novartis Investigative Site
-
San Isidro, Lima, Perù, 27
- Novartis Investigative Site
-
San Miguel, Lima, Perù, 32
- Novartis Investigative Site
-
-
-
-
-
Bialystok, Polonia, 15-875
- Novartis Investigative Site
-
Gdynia, Polonia, 81-157
- Novartis Investigative Site
-
Gdynia, Polonia, 81-472
- Novartis Investigative Site
-
Gdynia, Polonia, 81-548
- Novartis Investigative Site
-
Gdynia, Polonia, 81-519
- Novartis Investigative Site
-
Gliwice, Polonia, 44-100
- Novartis Investigative Site
-
Golub-Dobrzyn, Polonia, 87-400
- Novartis Investigative Site
-
Katowice, Polonia, 40-084
- Novartis Investigative Site
-
Katowice, Polonia, 40-645
- Novartis Investigative Site
-
Katowice, Polonia, 40-530
- Novartis Investigative Site
-
Krakow, Polonia, 30-082
- Novartis Investigative Site
-
Krakow, Polonia, 30-015
- Novartis Investigative Site
-
Kutno, Polonia, 99-300
- Novartis Investigative Site
-
Lodz, Polonia, 91-302
- Novartis Investigative Site
-
Lublin, Polonia, 20-857
- Novartis Investigative Site
-
Olawa, Polonia, 55-200
- Novartis Investigative Site
-
Skierniewice, Polonia, 96-100
- Novartis Investigative Site
-
Wroclaw, Polonia, 52-612
- Novartis Investigative Site
-
Wroclaw, Polonia, 50-088
- Novartis Investigative Site
-
Wroclaw, Polonia, 51-312
- Novartis Investigative Site
-
Zabrze, Polonia, 41-800
- Novartis Investigative Site
-
-
-
-
-
Amadora, Portogallo, 2720-276
- Novartis Investigative Site
-
Covilha, Portogallo, 6200-251
- Novartis Investigative Site
-
Guimarães, Portogallo, 4835-044
- Novartis Investigative Site
-
Lisboa, Portogallo, 1169-024
- Novartis Investigative Site
-
Lisboa, Portogallo, 1449-005
- Novartis Investigative Site
-
Penafiel, Portogallo, 4564-007
- Novartis Investigative Site
-
Portalegre, Portogallo, 7300-853
- Novartis Investigative Site
-
Porto, Portogallo, 4200-319
- Novartis Investigative Site
-
Setubal, Portogallo, 2910-446
- Novartis Investigative Site
-
-
Portuigal
-
Vila Real, Portuigal, Portogallo, 5000-508
- Novartis Investigative Site
-
-
-
-
-
Birmingham, Regno Unito, B18 7QH
- Novartis Investigative Site
-
Blackpool, Regno Unito, FY3 8NR
- Novartis Investigative Site
-
Bournemouth, Regno Unito, BH7 7DW
- Novartis Investigative Site
-
Bradford, Regno Unito, BD9 6RJ
- Novartis Investigative Site
-
Cheshire, Regno Unito, CW1 4QJ
- Novartis Investigative Site
-
Coventry, Regno Unito, CV2 2DX
- Novartis Investigative Site
-
Croydon, Regno Unito, CR7 7YE
- Novartis Investigative Site
-
Darlington, Regno Unito, DL3 6HX
- Novartis Investigative Site
-
Exeter, Regno Unito, EX2 5AX
- Novartis Investigative Site
-
Inverness, Regno Unito, IV2 3UJ
- Novartis Investigative Site
-
Kent, Regno Unito, DA2 8DA
- Novartis Investigative Site
-
Liverpool, Regno Unito, L7 8XP
- Novartis Investigative Site
-
London, Regno Unito, W1G 8PH
- Novartis Investigative Site
-
Londonderry, Regno Unito, BT47 1SB
- Novartis Investigative Site
-
Manchester, Regno Unito, M13 9WL
- Novartis Investigative Site
-
Middlesborough, Regno Unito, TS4 3BW
- Novartis Investigative Site
-
Milton Keynes, Regno Unito, MK6 5LD
- Novartis Investigative Site
-
Newport, Regno Unito, NP20 2UB
- Novartis Investigative Site
-
Newport, Regno Unito, P030 5TG
- Novartis Investigative Site
-
Norwich, Regno Unito, NR4 7UY
- Novartis Investigative Site
-
Poole, Regno Unito, BH15 2JB
- Novartis Investigative Site
-
Rotherham, Regno Unito, S60 2OD
- Novartis Investigative Site
-
Stevenage, Regno Unito, SG1 4AB
- Novartis Investigative Site
-
Sunderland, Regno Unito, SR4 7TP
- Novartis Investigative Site
-
Surrey, Regno Unito, SM5 1AA
- Novartis Investigative Site
-
Vale of Glamorgan, Regno Unito, CF64 2XX
- Novartis Investigative Site
-
Worcester, Regno Unito, WR5 1DD
- Novartis Investigative Site
-
York, Regno Unito, YO31 8HE
- Novartis Investigative Site
-
-
Bs2 8hw
-
Bristol, Bs2 8hw, Regno Unito
- Novartis Investigative Site
-
-
Cambrigdeshire
-
Cambridge, Cambrigdeshire, Regno Unito, CB2 0QQ
- Novartis Investigative Site
-
-
County Durham
-
Durham, County Durham, Regno Unito, DH1 5TW
- Novartis Investigative Site
-
-
Dorset
-
Dorchester, Dorset, Regno Unito, DT1 2JY
- Novartis Investigative Site
-
-
East Sussex
-
Brighton, East Sussex, Regno Unito, BN2 5BE
- Novartis Investigative Site
-
-
England
-
Swansea, England, Regno Unito, SA6 6NL
- Novartis Investigative Site
-
-
Essex
-
Romford, Essex, Regno Unito, RM7 0AG
- Novartis Investigative Site
-
-
Hampshire
-
Basingstoke, Hampshire, Regno Unito, RG24 9NA
- Novartis Investigative Site
-
Portsmouth, Hampshire, Regno Unito, PO6 3LY
- Novartis Investigative Site
-
-
Kent
-
Royal Bridge Wells, Kent, Regno Unito, TN4 8AT
- Novartis Investigative Site
-
-
Lancashire
-
Oldham, Lancashire, Regno Unito, OL1 2JH
- Novartis Investigative Site
-
-
Leicestershire
-
Leicester, Leicestershire, Regno Unito, LE2 7LX
- Novartis Investigative Site
-
-
Northern Ireland
-
Craigavon, Northern Ireland, Regno Unito, BT63 5QQ
- Novartis Investigative Site
-
-
Perthshire
-
Dundee, Perthshire, Regno Unito, DD1 2BU
- Novartis Investigative Site
-
-
Somerset
-
Taunton, Somerset, Regno Unito, TA1 5DA
- Novartis Investigative Site
-
Yeovil, Somerset, Regno Unito, BA21 4AT
- Novartis Investigative Site
-
-
South Yorkshire
-
Sheffield, South Yorkshire, Regno Unito, S10 2JF
- Novartis Investigative Site
-
-
Surrey
-
Redhill, Surrey, Regno Unito, RH1 5RH
- Novartis Investigative Site
-
-
Tyne and Wear
-
South Shields, Tyne and Wear, Regno Unito, NE34 0PL
- Novartis Investigative Site
-
-
West Midlands
-
Dudley, West Midlands, Regno Unito, DY1 2HQ
- Novartis Investigative Site
-
Sutton Coldfield, West Midlands, Regno Unito, B75 7RR
- Novartis Investigative Site
-
-
-
-
-
Beroun, Repubblica Ceca, 266 01
- Novartis Investigative Site
-
Brandys nad Labem, Repubblica Ceca, 250 01
- Novartis Investigative Site
-
Horovice, Repubblica Ceca, 268 01
- Novartis Investigative Site
-
Jablonec nad Nisou, Repubblica Ceca, 466 01
- Novartis Investigative Site
-
Karlovy Vary, Repubblica Ceca, 360 09
- Novartis Investigative Site
-
Kladno, Repubblica Ceca, 272 80
- Novartis Investigative Site
-
Klatovy, Repubblica Ceca, 339 01
- Novartis Investigative Site
-
Kolin, Repubblica Ceca, 280 20
- Novartis Investigative Site
-
Liberec V Kristianova, Repubblica Ceca, 460 05
- Novartis Investigative Site
-
Melnik, Repubblica Ceca, 276 01
- Novartis Investigative Site
-
Olomouc, Repubblica Ceca, 779 00
- Novartis Investigative Site
-
Plzen, Repubblica Ceca, 301 00
- Novartis Investigative Site
-
Prague 1, Repubblica Ceca, 110 00
- Novartis Investigative Site
-
Prague 10, Vrsovice, Repubblica Ceca, 10100
- Novartis Investigative Site
-
Prague 5, Repubblica Ceca, 150 30
- Novartis Investigative Site
-
Praha 2, Repubblica Ceca, 128 08
- Novartis Investigative Site
-
Praha 4, Repubblica Ceca, 142 00
- Novartis Investigative Site
-
Semily, Repubblica Ceca, 513 31
- Novartis Investigative Site
-
Strakonice, Repubblica Ceca, 38601
- Novartis Investigative Site
-
Trebic, Repubblica Ceca, 674 01
- Novartis Investigative Site
-
Uherske Hradiste, Repubblica Ceca, 686 01
- Novartis Investigative Site
-
Uherske Hradiste, Repubblica Ceca, 68601
- Novartis Investigative Site
-
Usti nad Labem, Repubblica Ceca, 400 01
- Novartis Investigative Site
-
-
CZE
-
Bilovec, CZE, Repubblica Ceca, 743 01
- Novartis Investigative Site
-
Praha 2, CZE, Repubblica Ceca, 128 08
- Novartis Investigative Site
-
-
-
-
-
Santo Domingo, Repubblica Dominicana
- Novartis Investigative Site
-
-
Republica Dominicana
-
Santo Domingo, Republica Dominicana, Repubblica Dominicana
- Novartis Investigative Site
-
-
-
-
-
Arad, Romania, 310158
- Novartis Investigative Site
-
Bucharest, Romania, 050098
- Novartis Investigative Site
-
Bucharest, Romania, 060011
- Novartis Investigative Site
-
Bucharest, Romania, 050659
- Novartis Investigative Site
-
Bucharest, Romania, 020054
- Novartis Investigative Site
-
Bucuresti, Romania, 062272
- Novartis Investigative Site
-
Bucuresti, Romania, 011728
- Novartis Investigative Site
-
Deva, Romania, 330084
- Novartis Investigative Site
-
Pitesti, Romania, 110114
- Novartis Investigative Site
-
Timisoara, Romania, 300736
- Novartis Investigative Site
-
Timisoara, Romania, 300041
- Novartis Investigative Site
-
Timisoara, Romania, 300310
- Novartis Investigative Site
-
Timisoara, Romania, 300020
- Novartis Investigative Site
-
Timisoara, Romania, 300361
- Novartis Investigative Site
-
-
District 1
-
Bucharest, District 1, Romania
- Novartis Investigative Site
-
Bucuresti, District 1, Romania, 014461
- Novartis Investigative Site
-
-
District 2
-
Bucuresti, District 2, Romania, 021345
- Novartis Investigative Site
-
-
District 5
-
Bucharest, District 5, Romania, 050538
- Novartis Investigative Site
-
-
Jud. Dolj
-
Craiova, Jud. Dolj, Romania, 200147
- Novartis Investigative Site
-
-
Jud.Dolj
-
Craiova, Jud.Dolj, Romania, 200235
- Novartis Investigative Site
-
-
Jud.Prahova
-
Ploiesti, Jud.Prahova, Romania, 100410
- Novartis Investigative Site
-
-
jud. Timis
-
Timisoara, jud. Timis, Romania, 300359
- Novartis Investigative Site
-
-
-
-
-
Singapore, Singapore, 119074
- Novartis Investigative Site
-
Singapore, Singapore, 308433
- Novartis Investigative Site
-
Singapore, Singapore, 169609
- Novartis Investigative Site
-
Singapore, Singapore, 768825
- Novartis Investigative Site
-
-
-
-
-
Bratislava, Slovacchia, 821 07
- Novartis Investigative Site
-
Bratislava, Slovacchia, 851 07
- Novartis Investigative Site
-
Bratislava, Slovacchia, 81369
- Novartis Investigative Site
-
Bratislava, Slovacchia, 841 04
- Novartis Investigative Site
-
Dolny Kubin, Slovacchia, 026 01
- Novartis Investigative Site
-
Dunajska Streda, Slovacchia, 929 01
- Novartis Investigative Site
-
Kosice, Slovacchia, 040 01
- Novartis Investigative Site
-
Kosice, Slovacchia, 04001
- Novartis Investigative Site
-
Kralovsky Chlmec, Slovacchia, 077 01
- Novartis Investigative Site
-
Levice, Slovacchia, 934 01
- Novartis Investigative Site
-
Levice, Slovacchia, 934 05
- Novartis Investigative Site
-
Lucenec, Slovacchia, 984 01
- Novartis Investigative Site
-
Martin, Slovacchia, 036 01
- Novartis Investigative Site
-
Nitra, Slovacchia, 949 88
- Novartis Investigative Site
-
Trnava, Slovacchia, 91701
- Novartis Investigative Site
-
Trnava, Slovacchia, 917 01
- Novartis Investigative Site
-
-
Slovak Republic
-
Bratislava, Slovak Republic, Slovacchia, 841 04
- Novartis Investigative Site
-
Brezno, Slovak Republic, Slovacchia, 977 42
- Novartis Investigative Site
-
Kosice, Slovak Republic, Slovacchia, 040 22
- Novartis Investigative Site
-
Levice, Slovak Republic, Slovacchia, 93401
- Novartis Investigative Site
-
Presov, Slovak Republic, Slovacchia, 08001
- Novartis Investigative Site
-
Presov, Slovak Republic, Slovacchia, 080 01
- Novartis Investigative Site
-
Svidnik, Slovak Republic, Slovacchia, 08901
- Novartis Investigative Site
-
Vranov nad Toplou, Slovak Republic, Slovacchia, 09301
- Novartis Investigative Site
-
-
-
-
-
Madrid, Spagna, 28007
- Novartis Investigative Site
-
-
Andalucia
-
Almeria, Andalucia, Spagna, 04120
- Novartis Investigative Site
-
Malaga, Andalucia, Spagna, 29010
- Novartis Investigative Site
-
Marbella, Andalucia, Spagna, 29600
- Novartis Investigative Site
-
Sevilla, Andalucia, Spagna, 41017
- Novartis Investigative Site
-
Sevilla, Andalucia, Spagna, 41014
- Novartis Investigative Site
-
-
Cataluna
-
Sant Joan Despi, Cataluna, Spagna, 08970
- Novartis Investigative Site
-
-
Catalunya
-
Barcelona, Catalunya, Spagna, 08035
- Novartis Investigative Site
-
Barcelona, Catalunya, Spagna, 08003
- Novartis Investigative Site
-
-
Comunidad Valenciana
-
Alicante, Comunidad Valenciana, Spagna, 03004
- Novartis Investigative Site
-
Valencia, Comunidad Valenciana, Spagna, 46010
- Novartis Investigative Site
-
Valencia, Comunidad Valenciana, Spagna, 46015
- Novartis Investigative Site
-
-
Extremadura
-
Mérida, Extremadura, Spagna, 06800
- Novartis Investigative Site
-
-
Galicia
-
A Coruna, Galicia, Spagna, 15006
- Novartis Investigative Site
-
Ferrol, Galicia, Spagna, 15405
- Novartis Investigative Site
-
La Coruna, Galicia, Spagna, 15006
- Novartis Investigative Site
-
Santiago de Compostela, Galicia, Spagna, 15706
- Novartis Investigative Site
-
Vigo, Galicia, Spagna, 36211
- Novartis Investigative Site
-
-
Islas Baleares
-
Mallorca, Islas Baleares, Spagna, 07198
- Novartis Investigative Site
-
-
Madrid
-
Alcala de Henares, Madrid, Spagna, 28805
- Novartis Investigative Site
-
Majadahonda, Madrid, Spagna, 28222
- Novartis Investigative Site
-
Mostoles, Madrid, Spagna, 28935
- Novartis Investigative Site
-
-
Murcia
-
El Palmar, Murcia, Spagna, 30120
- Novartis Investigative Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Stati Uniti, 35209
- Novartis Investigative Site
-
Birmingham, Alabama, Stati Uniti, 35211
- Novartis Investigative Site
-
Huntsville, Alabama, Stati Uniti, 35801
- Novartis Investigative Site
-
Mobile, Alabama, Stati Uniti, 36608
- Novartis Investigative Site
-
Muscle Shoals, Alabama, Stati Uniti, 35662
- Novartis Investigative Site
-
-
Alaska
-
Anchorage, Alaska, Stati Uniti, 99508
- Novartis Investigative Site
-
-
Arizona
-
Gilbert, Arizona, Stati Uniti, 85234
- Novartis Investigative Site
-
Phoenix, Arizona, Stati Uniti, 85020
- Novartis Investigative Site
-
Phoenix, Arizona, Stati Uniti, 85006
- Novartis Investigative Site
-
-
Arkansas
-
Little Rock, Arkansas, Stati Uniti, 72204
- Novartis Investigative Site
-
Little Rock, Arkansas, Stati Uniti, 72205
- Novartis Investigative Site
-
-
California
-
Anaheim, California, Stati Uniti, 92801
- Novartis Investigative Site
-
Bellflower, California, Stati Uniti, 90706
- Novartis Investigative Site
-
Berkley, California, Stati Uniti, 94705
- Novartis Investigative Site
-
Loma Linda, California, Stati Uniti, 92357
- Novartis Investigative Site
-
Los Angeles, California, Stati Uniti, 90033
- Novartis Investigative Site
-
Los Angeles, California, Stati Uniti, 90073
- Novartis Investigative Site
-
Mather, California, Stati Uniti, 95655
- Novartis Investigative Site
-
Oceanside, California, Stati Uniti, 92056
- Novartis Investigative Site
-
Palm Springs, California, Stati Uniti, 92262
- Novartis Investigative Site
-
Pomona, California, Stati Uniti, 91767
- Novartis Investigative Site
-
Sacramento, California, Stati Uniti, 95816
- Novartis Investigative Site
-
San Diego, California, Stati Uniti, 92161
- Novartis Investigative Site
-
San Diego, California, Stati Uniti, 92103
- Novartis Investigative Site
-
Santa Rosa, California, Stati Uniti, 95405
- Novartis Investigative Site
-
Stockton, California, Stati Uniti, 95204
- Novartis Investigative Site
-
Tustin, California, Stati Uniti, 92780
- Novartis Investigative Site
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80206
- Novartis Investigative Site
-
Denver, Colorado, Stati Uniti, 80220
- Novartis Investigative Site
-
-
Connecticut
-
Stamford, Connecticut, Stati Uniti, 06905
- Novartis Investigative Site
-
-
District of Columbia
-
Washington, District of Columbia, Stati Uniti, 20422
- Novartis Investigative Site
-
-
Florida
-
Boynton Beach, Florida, Stati Uniti, 33472-2952
- Novartis Investigative Site
-
Davie, Florida, Stati Uniti, 33324
- Novartis Investigative Site
-
Fort Lauderdale, Florida, Stati Uniti, 33316
- Novartis Investigative Site
-
Gainesville, Florida, Stati Uniti, 32608
- Novartis Investigative Site
-
Jacksonville, Florida, Stati Uniti, 32216
- Novartis Investigative Site
-
Jacksonville, Florida, Stati Uniti, 32223
- Novartis Investigative Site
-
Jacksonville, Florida, Stati Uniti, 32209-6511
- Novartis Investigative Site
-
Lakeland, Florida, Stati Uniti, 33805
- Novartis Investigative Site
-
Leesburg, Florida, Stati Uniti, 34748
- Novartis Investigative Site
-
Port Charlotte, Florida, Stati Uniti, 33952
- Novartis Investigative Site
-
Tamarac, Florida, Stati Uniti, 33321
- Novartis Investigative Site
-
Tampa, Florida, Stati Uniti, 33609
- Novartis Investigative Site
-
-
Georgia
-
Covington, Georgia, Stati Uniti, 30014
- Novartis Investigative Site
-
Decatur, Georgia, Stati Uniti, 30030
- Novartis Investigative Site
-
-
Hawaii
-
Honolulu, Hawaii, Stati Uniti, 96813
- Novartis Investigative Site
-
Honolulu, Hawaii, Stati Uniti, 96817
- Novartis Investigative Site
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60612
- Novartis Investigative Site
-
Maywood, Illinois, Stati Uniti, 60153
- Novartis Investigative Site
-
Melrose Park, Illinois, Stati Uniti, 60160
- Novartis Investigative Site
-
Park Ridge, Illinois, Stati Uniti, 60068
- Novartis Investigative Site
-
Quincy, Illinois, Stati Uniti, 62301
- Novartis Investigative Site
-
-
Iowa
-
Des Moines, Iowa, Stati Uniti, 50314
- Novartis Investigative Site
-
-
Kansas
-
Pratt, Kansas, Stati Uniti, 67124
- Novartis Investigative Site
-
Topeka, Kansas, Stati Uniti, 66606
- Novartis Investigative Site
-
Wichita, Kansas, Stati Uniti, 67207
- Novartis Investigative Site
-
-
Louisiana
-
Alexandria, Louisiana, Stati Uniti, 71301
- Novartis Investigative Site
-
Covington, Louisiana, Stati Uniti, 70433
- Novartis Investigative Site
-
Lafayette, Louisiana, Stati Uniti, 70501
- Novartis Investigative Site
-
Slidell, Louisiana, Stati Uniti, 70458
- Novartis Investigative Site
-
-
Maine
-
Biddeford, Maine, Stati Uniti, 04005
- Novartis Investigative Site
-
South Portland, Maine, Stati Uniti, 04106
- Novartis Investigative Site
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21208
- Novartis Investigative Site
-
Beltsville, Maryland, Stati Uniti, 20705
- Novartis Investigative Site
-
Columbia, Maryland, Stati Uniti, 21044
- Novartis Investigative Site
-
Nottingham, Maryland, Stati Uniti, 21236
- Novartis Investigative Site
-
-
Massachusetts
-
Ayer, Massachusetts, Stati Uniti, 01432
- Novartis Investigative Site
-
Boston, Massachusetts, Stati Uniti
- Novartis Investigative Site
-
Haverhill, Massachusetts, Stati Uniti, 01830
- Novartis Investigative Site
-
Natick, Massachusetts, Stati Uniti, 01760
- Novartis Investigative Site
-
-
Michigan
-
Ann Arbor, Michigan, Stati Uniti, 48106
- Novartis Investigative Site
-
Detroit, Michigan, Stati Uniti, 48202
- Novartis Investigative Site
-
Lapeer, Michigan, Stati Uniti, 48446
- Novartis Investigative Site
-
Saginaw, Michigan, Stati Uniti, 48601
- Novartis Investigative Site
-
-
Minnesota
-
Minneapolis, Minnesota, Stati Uniti, 55417
- Novartis Investigative Site
-
St. Paul, Minnesota, Stati Uniti, 55102
- Novartis Investigative Site
-
-
Mississippi
-
Picayune, Mississippi, Stati Uniti, 39466
- Novartis Investigative Site
-
Rolling Fork, Mississippi, Stati Uniti, 39159
- Novartis Investigative Site
-
-
Missouri
-
Springfield, Missouri, Stati Uniti, 65804
- Novartis Investigative Site
-
Springfield, Missouri, Stati Uniti, 65807
- Novartis Investigative Site
-
-
Nebraska
-
Fremont, Nebraska, Stati Uniti, 68025
- Novartis Investigative Site
-
Grand Island, Nebraska, Stati Uniti, 68803
- Novartis Investigative Site
-
Omaha, Nebraska, Stati Uniti, 68131
- Novartis Investigative Site
-
-
New Hampshire
-
Nashua, New Hampshire, Stati Uniti, 03060
- Novartis Investigative Site
-
-
New Jersey
-
Elizabeth, New Jersey, Stati Uniti, 07202
- Novartis Investigative Site
-
Hamilton, New Jersey, Stati Uniti, 08690
- Novartis Investigative Site
-
New Brunswick, New Jersey, Stati Uniti, 08901
- Novartis Investigative Site
-
Newark, New Jersey, Stati Uniti, 07103-2714
- Novartis Investigative Site
-
Ocean, New Jersey, Stati Uniti, 07712
- Novartis Investigative Site
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87102
- Novartis Investigative Site
-
-
New York
-
Cordtlandt Manor, New York, Stati Uniti, 10567
- Novartis Investigative Site
-
Laurelton, New York, Stati Uniti, 11422
- Novartis Investigative Site
-
New York, New York, Stati Uniti, 10032
- Novartis Investigative Site
-
Northport, New York, Stati Uniti, 11768
- Novartis Investigative Site
-
-
North Carolina
-
Asheboro, North Carolina, Stati Uniti, 27204
- Novartis Investigative Site
-
Asheville, North Carolina, Stati Uniti, 28803
- Novartis Investigative Site
-
Cary, North Carolina, Stati Uniti, 27511
- Novartis Investigative Site
-
Greensboro, North Carolina, Stati Uniti, 27401
- Novartis Investigative Site
-
Raleigh, North Carolina, Stati Uniti, 27610
- Novartis Investigative Site
-
Wilmington, North Carolina, Stati Uniti, 28401
- Novartis Investigative Site
-
-
Ohio
-
Cadiz, Ohio, Stati Uniti, 43907
- Novartis Investigative Site
-
Canton, Ohio, Stati Uniti, 44710
- Novartis Investigative Site
-
Cincinnati, Ohio, Stati Uniti, 45219
- Novartis Investigative Site
-
Cincinnati, Ohio, Stati Uniti, 45267-0585
- Novartis Investigative Site
-
Cleveland, Ohio, Stati Uniti, 44195
- Novartis Investigative Site
-
Columbus, Ohio, Stati Uniti, 43210
- Novartis Investigative Site
-
Marion, Ohio, Stati Uniti, 43302
- Novartis Investigative Site
-
-
Oklahoma
-
Bartlesville, Oklahoma, Stati Uniti, 74006
- Novartis Investigative Site
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- Novartis Investigative Site
-
Oklahoma City, Oklahoma, Stati Uniti, 73120
- Novartis Investigative Site
-
Stillwater, Oklahoma, Stati Uniti, 74074
- Novartis Investigative Site
-
Tulsa, Oklahoma, Stati Uniti, 74136
- Novartis Investigative Site
-
Tulsa, Oklahoma, Stati Uniti, 74104-4243
- Novartis Investigative Site
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97239-3098
- Novartis Investigative Site
-
-
Pennsylvania
-
Aliquippa, Pennsylvania, Stati Uniti, 15001
- Novartis Investigative Site
-
Beaver, Pennsylvania, Stati Uniti, 15009
- Novartis Investigative Site
-
Philadelphia, Pennsylvania, Stati Uniti, 19102-1192
- Novartis Investigative Site
-
Pittsburgh, Pennsylvania, Stati Uniti, 15206
- Novartis Investigative Site
-
-
South Carolina
-
Charleston, South Carolina, Stati Uniti, 29401-5799
- Novartis Investigative Site
-
-
South Dakota
-
Rapid City, South Dakota, Stati Uniti, 57701
- Novartis Investigative Site
-
-
Tennessee
-
Memphis, Tennessee, Stati Uniti, 38104
- Novartis Investigative Site
-
Nashville, Tennessee, Stati Uniti, 37203
- Novartis Investigative Site
-
Nashville, Tennessee, Stati Uniti, 37212
- Novartis Investigative Site
-
-
Texas
-
Amarillo, Texas, Stati Uniti, 79106
- Novartis Investigative Site
-
Arlington, Texas, Stati Uniti, 76012
- Novartis Investigative Site
-
Beaumont, Texas, Stati Uniti, 77702
- Novartis Investigative Site
-
Beaumont, Texas, Stati Uniti, 77701
- Novartis Investigative Site
-
Brownsville, Texas, Stati Uniti, 78520
- Novartis Investigative Site
-
Dallas, Texas, Stati Uniti, 75235
- Novartis Investigative Site
-
Dallas, Texas, Stati Uniti, 75231
- Novartis Investigative Site
-
Dallas, Texas, Stati Uniti, 75390
- Novartis Investigative Site
-
Dallas, Texas, Stati Uniti, 75251
- Novartis Investigative Site
-
Grapevine, Texas, Stati Uniti, 76051
- Novartis Investigative Site
-
Houston, Texas, Stati Uniti, 77030
- Novartis Investigative Site
-
Houston, Texas, Stati Uniti, 77025
- Novartis Investigative Site
-
Houston, Texas, Stati Uniti, 77081
- Novartis Investigative Site
-
Houston, Texas, Stati Uniti, 77024
- Novartis Investigative Site
-
Houston, Texas, Stati Uniti, 77070
- Novartis Investigative Site
-
Kingwood, Texas, Stati Uniti, 77339
- Novartis Investigative Site
-
Livingston, Texas, Stati Uniti, 77351
- Novartis Investigative Site
-
Lufkin, Texas, Stati Uniti, 75904
- Novartis Investigative Site
-
Odessa, Texas, Stati Uniti, 79761
- Novartis Investigative Site
-
Plano, Texas, Stati Uniti, 75024
- Novartis Investigative Site
-
Tyler, Texas, Stati Uniti, 75701
- Novartis Investigative Site
-
-
Utah
-
Layton, Utah, Stati Uniti, 84041
- Novartis Investigative Site
-
-
Virginia
-
Fredericksburg, Virginia, Stati Uniti, 22401
- Novartis Investigative Site
-
Richmond, Virginia, Stati Uniti, 23219
- Novartis Investigative Site
-
Richmond, Virginia, Stati Uniti, 23249
- Novartis Investigative Site
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98103
- Novartis Investigative Site
-
Spokane, Washington, Stati Uniti, 99204
- Novartis Investigative Site
-
Tacoma, Washington, Stati Uniti, 98405
- Novartis Investigative Site
-
-
Wisconsin
-
Madison, Wisconsin, Stati Uniti, 53792-1615
- Novartis Investigative Site
-
Milwaukee, Wisconsin, Stati Uniti, 53295
- Novartis Investigative Site
-
Waukesha, Wisconsin, Stati Uniti, 53188
- Novartis Investigative Site
-
Wausau, Wisconsin, Stati Uniti, 54401
- Novartis Investigative Site
-
-
-
-
-
Alberton, Sud Africa, 1449
- Novartis Investigative Site
-
Bloemfontein, Sud Africa, 9301
- Novartis Investigative Site
-
Bloemfontein, Sud Africa, 9317
- Novartis Investigative Site
-
Breyton, Sud Africa, 2330
- Novartis Investigative Site
-
Brits, Sud Africa, 250
- Novartis Investigative Site
-
Cape Town, Sud Africa, 7500
- Novartis Investigative Site
-
Cape Town, Sud Africa, 7531
- Novartis Investigative Site
-
Cape Town, Sud Africa, 7505
- Novartis Investigative Site
-
Cape Town, Sud Africa, 7405
- Novartis Investigative Site
-
Cape Town, Sud Africa
- Novartis Investigative Site
-
Durban, Sud Africa, 4001
- Novartis Investigative Site
-
Durban, Sud Africa, 4110
- Novartis Investigative Site
-
Durban, Sud Africa, 4052
- Novartis Investigative Site
-
East London, Sud Africa
- Novartis Investigative Site
-
Gatesville, Sud Africa, 7764
- Novartis Investigative Site
-
Johannesburg, Sud Africa, 2193
- Novartis Investigative Site
-
Kempton Park, Sud Africa, 1620
- Novartis Investigative Site
-
Port Elizabeth, Sud Africa, 6014
- Novartis Investigative Site
-
Pretoria, Sud Africa, 0184
- Novartis Investigative Site
-
Pretoria, Sud Africa
- Novartis Investigative Site
-
Pretoria, Sud Africa, 0121
- Novartis Investigative Site
-
Umkomaas, Sud Africa, 4170
- Novartis Investigative Site
-
Witbank, Sud Africa
- Novartis Investigative Site
-
Worcester, Sud Africa, 6850
- Novartis Investigative Site
-
-
Eastern Cape
-
Mthatha, Eastern Cape, Sud Africa
- Novartis Investigative Site
-
-
Free State
-
Bloemfontein, Free State, Sud Africa, 9301
- Novartis Investigative Site
-
-
Gauteng
-
Soweto, Gauteng, Sud Africa, 2013
- Novartis Investigative Site
-
-
Mpumalanga
-
Middelburg, Mpumalanga, Sud Africa, 1050
- Novartis Investigative Site
-
-
Western Cape
-
Paarl, Western Cape, Sud Africa, 7626
- Novartis Investigative Site
-
Somerset West, Western Cape, Sud Africa, 7130
- Novartis Investigative Site
-
-
-
-
-
Göteborg, Svezia, 416 85
- Novartis Investigative Site
-
Göteborg, Svezia
- Novartis Investigative Site
-
Helsingborg, Svezia, 25232
- Novartis Investigative Site
-
Härnösand, Svezia, 871 82
- Novartis Investigative Site
-
Karlshamn, Svezia, 37480
- Novartis Investigative Site
-
Lund, Svezia, 221 85
- Novartis Investigative Site
-
Motala, Svezia, 59185
- Novartis Investigative Site
-
Stockholm, Svezia, 141 86
- Novartis Investigative Site
-
Vällingby, Svezia, 162 68
- Novartis Investigative Site
-
-
-
-
-
Adana, Tacchino, 01250
- Novartis Investigative Site
-
Ankara, Tacchino, 06100
- Novartis Investigative Site
-
Antalya, Tacchino, 07070
- Novartis Investigative Site
-
Balcova / Izmir, Tacchino, 35340
- Novartis Investigative Site
-
Edirne, Tacchino, 22030
- Novartis Investigative Site
-
Etlik / Ankara, Tacchino, 06018
- Novartis Investigative Site
-
Haseki / Istanbul, Tacchino, 34096
- Novartis Investigative Site
-
Istanbul, Tacchino, 34093
- Novartis Investigative Site
-
Istanbul, Tacchino, 34304
- Novartis Investigative Site
-
Izmir, Tacchino, 35040
- Novartis Investigative Site
-
Kocaeli, Tacchino, 41380
- Novartis Investigative Site
-
Mersin, Tacchino, 33079
- Novartis Investigative Site
-
Meselik / Eskisehir, Tacchino, 26480
- Novartis Investigative Site
-
Sivas, Tacchino, 58140
- Novartis Investigative Site
-
-
-
-
-
Bangkok, Tailandia, 10400
- Novartis Investigative Site
-
Khon Kaen, Tailandia, 40002
- Novartis Investigative Site
-
Muang, Tailandia, 65000
- Novartis Investigative Site
-
Muang, Tailandia, 12120
- Novartis Investigative Site
-
-
Nonthaburi
-
Taladkwan, Nonthaburi, Tailandia, 11000
- Novartis Investigative Site
-
-
-
-
-
Changhua, Taiwan, 500
- Novartis Investigative Site
-
Ilan, Taiwan
- Novartis Investigative Site
-
Kaohsiung, Taiwan, 82445
- Novartis Investigative Site
-
Taichung, Taiwan, 40447
- Novartis Investigative Site
-
Taipei, Taiwan, 10002
- Novartis Investigative Site
-
Taipei, Taiwan, 114
- Novartis Investigative Site
-
-
Taiwan ROC
-
Tainan 704, Taiwan ROC, Taiwan
- Novartis Investigative Site
-
-
Taiwan, ROC
-
Taipei, Taiwan, ROC, Taiwan, 112
- Novartis Investigative Site
-
-
-
-
-
Baja, Ungheria, 6500
- Novartis Investigative Site
-
Balatonfured, Ungheria, H-8231
- Novartis Investigative Site
-
Budapest, Ungheria, 1125
- Novartis Investigative Site
-
Budapest, Ungheria, 1145
- Novartis Investigative Site
-
Budapest, Ungheria, 1085
- Novartis Investigative Site
-
Budapest, Ungheria, 1134
- Novartis Investigative Site
-
Budapest, Ungheria, 1027
- Novartis Investigative Site
-
Budapest, Ungheria, 1122
- Novartis Investigative Site
-
Budapest, Ungheria, H-1032
- Novartis Investigative Site
-
Budapest, Ungheria, 1096
- Novartis Investigative Site
-
Budapest, Ungheria, 1043
- Novartis Investigative Site
-
Budapest, Ungheria, H-1096
- Novartis Investigative Site
-
Budapest, Ungheria, 1021
- Novartis Investigative Site
-
Budapest, Ungheria, H-1106
- Novartis Investigative Site
-
Cegled, Ungheria, 2700
- Novartis Investigative Site
-
Debrecen, Ungheria, 4032
- Novartis Investigative Site
-
Eger, Ungheria, H-3300
- Novartis Investigative Site
-
Hodmezovasarhely, Ungheria, 6800
- Novartis Investigative Site
-
Kaposvár, Ungheria, 7400
- Novartis Investigative Site
-
Miskolc, Ungheria, 3526
- Novartis Investigative Site
-
Nagykanizsa, Ungheria, 8800
- Novartis Investigative Site
-
Nyiregyháza, Ungheria, 4400
- Novartis Investigative Site
-
Pecs, Ungheria, 7643
- Novartis Investigative Site
-
Sopron, Ungheria, 9400
- Novartis Investigative Site
-
Szeged, Ungheria, H-6720
- Novartis Investigative Site
-
Szekesfehervar, Ungheria, 8000
- Novartis Investigative Site
-
Szekszard, Ungheria, 7100
- Novartis Investigative Site
-
Zalaegerszeg, Ungheria, 8900
- Novartis Investigative Site
-
-
Baranya
-
Pecs, Baranya, Ungheria, 7621
- Novartis Investigative Site
-
-
-
-
Distrito Capital
-
Caracas, Distrito Capital, Venezuela, 1060
- Novartis Investigative Site
-
-
Estado Miranda
-
Caracas, Estado Miranda, Venezuela, 1061
- Novartis Investigative Site
-
-
Estado Monagas
-
Maturin, Estado Monagas, Venezuela, 6201
- Novartis Investigative Site
-
-
Estado Zulia
-
Maracaibo, Estado Zulia, Venezuela, 4011
- Novartis Investigative Site
-
Maracaibo, Estado Zulia, Venezuela
- Novartis Investigative Site
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
18 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Criterio di inclusione:
- I pazienti devono dare il consenso informato scritto prima che venga eseguita qualsiasi valutazione.
- Pazienti ambulatoriali ≥ 18 anni di età, maschi o femmine.
- Pazienti con diagnosi di CHF NYHA classe II-IV e ridotta frazione di eiezione (FE = < 35%) e BNP elevato.
- I pazienti devono assumere un ACEI o un ARB a una dose stabile di almeno enalapril 10 mg/die o equivalente per almeno 4 settimane.
- I pazienti devono essere trattati con un β-bloccante, a meno che non sia controindicato o non tollerato, a una dose stabile per almeno 4 settimane.
Criteri di esclusione:
- Uso di altri farmaci sperimentali al momento dell'arruolamento o entro 30 giorni o 5 emivite dall'arruolamento, a seconda di quale sia il periodo più lungo.
- Storia di ipersensibilità o allergia a uno qualsiasi dei farmaci in studio, farmaci di classi chimiche simili, ACEI, ARB o inibitori della NEP, nonché controindicazioni note o sospette ai farmaci in studio.
- Storia precedente di intolleranza alle dosi target raccomandate di ACEI o ARB
- Storia nota di angioedema.
- Requisito del trattamento sia con ACEI che con ARB.
- Insufficienza cardiaca scompensata acuta in corso (esacerbazione di insufficienza cardiaca cronica manifestata da segni e sintomi che possono richiedere una terapia endovenosa).
- Ipotensione sintomatica e/o PAS < 100 mmHg.
- VFG stimato < 30 ml/min/1,73 m2 come misurato dalla formula MDRD semplificata
- Potassio sierico > 5,2 mmol/L.
Potrebbero essere applicati altri criteri di inclusione/esclusione definiti dal protocollo.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: LCZ696
Il periodo di run-in attivo in singolo cieco consisteva nel trattamento con enalapril 10 mg bid, seguito da LCZ696 100 mg bid, e quindi LCZ696 200 mg bid per una durata totale da 5 a 10 settimane.
Era consentita una riduzione temporanea della titolazione da LCZ696 200 mg bid a LCZ696 100 mg bid a condizione che il paziente fosse titolato di nuovo a LCZ696 200 mg bid e tollerasse questa dose per almeno due settimane prima di essere idoneo per la randomizzazione.
LCZ696 200mg BID durante il periodo di trattamento in doppio cieco
|
LCZ696 200 mg BID
|
|
Comparatore attivo: Enalapril
Il periodo di run-in attivo in singolo cieco consisteva nel trattamento con enalapril 10 mg bid, seguito da LCZ696 100 mg bid, e quindi LCZ696 200 mg bid per una durata totale da 5 a 10 settimane.
Era consentita una riduzione temporanea della titolazione da LCZ696 200 mg bid a LCZ696 100 mg bid a condizione che il paziente fosse titolato di nuovo a LCZ696 200 mg bid e tollerasse questa dose per almeno due settimane prima di essere idoneo per la randomizzazione.
Enalapril 10 mg BID durante il periodo di trattamento in doppio cieco
|
Enalapril 10 mg BID
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Numero di partecipanti che hanno avuto la prima occorrenza dell'endpoint composito, che è definito come decesso cardiovascolare (CV) o ricovero per insufficienza cardiaca (HF)
Lasso di tempo: fino a 51 mesi
|
Numero di partecipanti che hanno avuto la prima occorrenza dell'endpoint composito, che è definito come morte CV o ricovero per scompenso cardiaco dovuto a scompenso cardiaco.
|
fino a 51 mesi
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Numero di pazienti - Mortalità per tutte le cause
Lasso di tempo: fino a 51 mesi
|
Numero di pazienti - Mortalità per tutte le cause.
La mortalità per tutte le cause è comune nei pazienti con scompenso cardiaco e misura quanti pazienti hanno avuto questo evento.
I dati si riferiscono alla popolazione FAS fino al 31 marzo 2014
|
fino a 51 mesi
|
|
Numero di pazienti segnalati con cause primarie di morte giudicate
Lasso di tempo: fino a 51 mesi
|
Numero di pazienti segnalati con cause primarie di morte giudicate.
I dati si riferiscono alla popolazione randomizzata fino al 31 marzo 2014
|
fino a 51 mesi
|
|
Modifica dal basale al mese 8 per il punteggio di riepilogo clinico del Kansas City Cardiomyopathy Questionnaire (KCCQ)
Lasso di tempo: Riferimento, mese 8
|
Variazione dal basale al mese 8 per il punteggio riassuntivo clinico del Kansas City Cardiomyopathy Questionnaire (KCCQ).
KCCQ è uno strumento autosomministrato di 23 item che quantifica la funzione fisica, i sintomi (frequenza, gravità e cambiamento recente), la funzione sociale, l'autoefficacia e la conoscenza e la qualità della vita.
Il punteggio riassuntivo clinico KCCQ è una valutazione composita delle limitazioni fisiche e dei punteggi totali dei sintomi.
I punteggi vengono trasformati in un intervallo compreso tra 0 e 100, in cui i punteggi più alti riflettono un migliore stato di salute.
|
Riferimento, mese 8
|
|
Numero di pazienti con prima disfunzione renale confermata
Lasso di tempo: fino a 51 mesi
|
Numero di pazienti con prima disfunzione renale confermata
|
fino a 51 mesi
|
|
Percentuale di partecipanti con nuova insorgenza di fibrillazione atriale (FA)
Lasso di tempo: fino a 51 mesi
|
Percentuale di partecipanti con fibrillazione atriale di nuova insorgenza L'analisi della fibrillazione atriale (FA) di nuova insorgenza si basava su un sottogruppo di FAS: vale a dire, per i pazienti senza una storia di FA al basale (i pazienti con una storia di FA sono stati esclusi da questa analisi) .
|
fino a 51 mesi
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Vaduganathan M, Claggett BL, McMurray JJV, Solomon SD. Health Status Trajectories Before and After Hospitalization for Heart Failure. Circulation. 2022 Jun 21;145(25):1872-1874. doi: 10.1161/CIRCULATIONAHA.122.059282. Epub 2022 May 21. No abstract available.
- Shen L, Jhund PS, Anand IS, Bhatt AS, Desai AS, Maggioni AP, Martinez FA, Pfeffer MA, Rizkala AR, Rouleau JL, Swedberg K, Vaduganathan M, Vardeny O, van Veldhuisen DJ, Zannad F, Zile MR, Packer M, Solomon SD, McMurray JJV. Incidence and Outcomes of Pneumonia in Patients With Heart Failure. J Am Coll Cardiol. 2021 Apr 27;77(16):1961-1973. doi: 10.1016/j.jacc.2021.03.001.
- Solomon SD, Vaduganathan M, L Claggett B, Packer M, Zile M, Swedberg K, Rouleau J, A Pfeffer M, Desai A, Lund LH, Kober L, Anand I, Sweitzer N, Linssen G, Merkely B, Luis Arango J, Vinereanu D, Chen CH, Senni M, Sibulo A, Boytsov S, Shi V, Rizkala A, Lefkowitz M, McMurray JJV. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure. Circulation. 2020 Feb 4;141(5):352-361. doi: 10.1161/CIRCULATIONAHA.119.044586. Epub 2019 Nov 17.
- Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD; PARAGON-HF Investigators. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 Oct;7(10):862-874. doi: 10.1016/j.jchf.2019.05.015. Epub 2019 Jul 10.
- Andersen MB, Simonsen U, Wehland M, Pietsch J, Grimm D. LCZ696 (Valsartan/Sacubitril)--A Possible New Treatment for Hypertension and Heart Failure. Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):14-22. doi: 10.1111/bcpt.12453. Epub 2015 Sep 4.
- Shen L, Claggett BL, Jhund PS, Abraham WT, Desai AS, Dickstein K, Gong J, Kober LV, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, McMurray JJV. Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. Clin Res Cardiol. 2021 Aug;110(8):1334-1349. doi: 10.1007/s00392-021-01888-x. Epub 2021 Jun 8.
- Kristensen SL, Castagno D, Shen L, Jhund PS, Docherty KF, Rorth R, Abraham WT, Desai AS, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Kober L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Committees and Investigators.. Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020 Dec;22(12):2370-2379. doi: 10.1002/ejhf.1972. Epub 2020 Sep 14.
- Docherty KF, Shen L, Castagno D, Petrie MC, Abraham WT, Bohm M, Desai AS, Dickstein K, Kober LV, Packer M, Rouleau JL, Solomon SD, Swedberg K, Vazir A, Zile MR, Jhund PS, McMurray JJV. Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. Eur J Heart Fail. 2020 Mar;22(3):528-538. doi: 10.1002/ejhf.1682. Epub 2019 Dec 17.
- Dewan P, Rorth R, Raparelli V, Campbell RT, Shen L, Jhund PS, Petrie MC, Anand IS, Carson PE, Desai AS, Granger CB, Kober L, Komajda M, McKelvie RS, O'Meara E, Pfeffer MA, Pitt B, Solomon SD, Swedberg K, Zile MR, McMurray JJV. Sex-Related Differences in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2019 Dec;12(12):e006539. doi: 10.1161/CIRCHEARTFAILURE.119.006539. Epub 2019 Dec 9. Erratum In: Circ Heart Fail. 2020 Jan;13(1):e000036.
- Shen L, Ramires F, Martinez F, Bodanese LC, Echeverria LE, Gomez EA, Abraham WT, Dickstein K, Kober L, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Jhund PS, Gimpelewicz CR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators and Committees. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. Circ Heart Fail. 2017 Nov;10(11):e004361. doi: 10.1161/CIRCHEARTFAILURE.117.004361.
- Kristensen SL, Jhund PS, Mogensen UM, Rorth R, Abraham WT, Desai A, Dickstein K, Rouleau JL, Zile MR, Swedberg K, Packer M, Solomon SD, Kober L, McMurray JJV; PARADIGM-HF and ATMOSPHERE Committees and Investigators. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Circ Heart Fail. 2017 Oct;10(10):e004409. doi: 10.1161/CIRCHEARTFAILURE.117.004409.
- Toenges G, Mutze T, Jahn-Eimermacher A. A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials. Stat Med. 2021 Nov 20;40(26):5702-5724. doi: 10.1002/sim.9149. Epub 2021 Jul 30.
- Ehteshami-Afshar S, Mooney L, Dewan P, Desai AS, Lang NN, Lefkowitz MP, Petrie MC, Rizkala AR, Rouleau JL, Solomon SD, Swedberg K, Shi VC, Zile MR, Packer M, McMurray JJV, Jhund PS, Hawkins NM. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF. J Am Heart Assoc. 2021 Feb 16;10(4):e019238. doi: 10.1161/JAHA.120.019238. Epub 2021 Jan 30.
- Selvaraj S, Claggett B, Pozzi A, McMurray JJV, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF. Circulation. 2019 Oct 22;140(17):1369-1379. doi: 10.1161/CIRCULATIONAHA.119.039920. Epub 2019 Sep 12.
- Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC Heart Fail. 2019 Jun;7(6):457-465. doi: 10.1016/j.jchf.2019.02.015. Epub 2019 May 8.
- Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272. doi: 10.1016/j.jacc.2019.01.018. Epub 2019 Mar 4.
- Zile MR, O'Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefkowitz M, Rouleau J. Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF. J Am Coll Cardiol. 2019 Feb 26;73(7):795-806. doi: 10.1016/j.jacc.2018.11.042.
- Bouabdallaoui N, Claggett B, Zile MR, McMurray JJV, O'Meara E, Packer M, Prescott MF, Swedberg K, Solomon SD, Rouleau JL; PARADIGM-HF Investigators and Committees. Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2018 Dec;20(12):1701-1709. doi: 10.1002/ejhf.1301. Epub 2018 Sep 11.
- O'Meara E, Prescott MF, Claggett B, Rouleau JL, Chiang LM, Solomon SD, Packer M, McMurray JJV, Zile MR. Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure). Circ Heart Fail. 2018 May;11(5):e004446. doi: 10.1161/CIRCHEARTFAILURE.117.004446.
- Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, Zile MR. Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. Lancet Diabetes Endocrinol. 2018 Jul;6(7):547-554. doi: 10.1016/S2213-8587(18)30100-1. Epub 2018 Apr 13.
- Chandra A, Lewis EF, Claggett BL, Desai AS, Packer M, Zile MR, Swedberg K, Rouleau JL, Shi VC, Lefkowitz MP, Katova T, McMurray JJV, Solomon SD. Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial. JAMA Cardiol. 2018 Jun 1;3(6):498-505. doi: 10.1001/jamacardio.2018.0398.
- Lewis EF, Claggett BL, McMurray JJV, Packer M, Lefkowitz MP, Rouleau JL, Liu J, Shi VC, Zile MR, Desai AS, Solomon SD, Swedberg K. Health-Related Quality of Life Outcomes in PARADIGM-HF. Circ Heart Fail. 2017 Aug;10(8):e003430. doi: 10.1161/CIRCHEARTFAILURE.116.003430.
- Zile MR, Claggett BL, Prescott MF, McMurray JJ, Packer M, Rouleau JL, Swedberg K, Desai AS, Gong J, Shi VC, Solomon SD. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. J Am Coll Cardiol. 2016 Dec 6;68(22):2425-2436. doi: 10.1016/j.jacc.2016.09.931.
- Nadruz W Jr, Claggett BL, McMurray JJ, Packer M, Zile MR, Rouleau JL, Desai AS, Swedberg K, Lefkowitz M, Shi VC, Prescott MF, Solomon SD. Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial). Circulation. 2016 Nov 29;134(22):1785-1787. doi: 10.1161/CIRCULATIONAHA.116.024976. No abstract available.
- Desai AS, Vardeny O, Claggett B, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Zile MR, Lefkowitz M, Shi V, Solomon SD. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial. JAMA Cardiol. 2017 Jan 1;2(1):79-85. doi: 10.1001/jamacardio.2016.4733.
- Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ; PARADIGM-HF Investigators and Committees*. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy. Circ Heart Fail. 2016 Sep;9(9):e003212. doi: 10.1161/CIRCHEARTFAILURE.116.003212.
- Solomon SD, Claggett B, Packer M, Desai A, Zile MR, Swedberg K, Rouleau J, Shi V, Lefkowitz M, McMurray JJV. Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial. JACC Heart Fail. 2016 Oct;4(10):816-822. doi: 10.1016/j.jchf.2016.05.002. Epub 2016 Jul 6.
- Kristensen SL, Martinez F, Jhund PS, Arango JL, Belohlavek J, Boytsov S, Cabrera W, Gomez E, Hagege AA, Huang J, Kiatchoosakun S, Kim KS, Mendoza I, Senni M, Squire IB, Vinereanu D, Wong RC, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJ. Geographic variations in the PARADIGM-HF heart failure trial. Eur Heart J. 2016 Nov 1;37(41):3167-3174. doi: 10.1093/eurheartj/ehw226. Epub 2016 Jun 28.
- Desai AS, Solomon S, Claggett B, McMurray JJ, Rouleau J, Swedberg K, Zile M, Lefkowitz M, Shi V, Packer M. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial. Circ Heart Fail. 2016 Jun;9(6):e002735. doi: 10.1161/CIRCHEARTFAILURE.115.002735.
- Okumura N, Jhund PS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ; PARADIGM-HF Investigators and Committees*. Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF). Circulation. 2016 Jun 7;133(23):2254-62. doi: 10.1161/CIRCULATIONAHA.115.020729. Epub 2016 Apr 20.
- Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, Rouleau JL, Shi VC, Starling RC, Kozan O, Dukat A, Lefkowitz MP, McMurray JJ. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744.
- Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial. Circ Heart Fail. 2016 Jan;9(1):e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.
- Simpson J, Jhund PS, Silva Cardoso J, Martinez F, Mosterd A, Ramires F, Rizkala AR, Senni M, Squire I, Gong J, Lefkowitz MP, Shi VC, Desai AS, Rouleau JL, Swedberg K, Zile MR, McMurray JJV, Packer M, Solomon SD; PARADIGM-HF Investigators and Committees. Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF. J Am Coll Cardiol. 2015 Nov 10;66(19):2059-2071. doi: 10.1016/j.jacc.2015.08.878.
- Jhund PS, Fu M, Bayram E, Chen CH, Negrusz-Kawecka M, Rosenthal A, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees. Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. Eur Heart J. 2015 Oct 7;36(38):2576-84. doi: 10.1093/eurheartj/ehv330. Epub 2015 Jul 31.
- Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F, Gong J, Rizkala AR, Brahimi A, Claggett B, Finn PV, Hartley LH, Liu J, Lefkowitz M, Shi V, Zile MR, Solomon SD. Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J. 2015 Aug 7;36(30):1990-7. doi: 10.1093/eurheartj/ehv186. Epub 2015 May 28.
- McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Belohlavek J, Bohm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R; PARADIGM-HF Committees and Investigators. A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J. 2015 Feb 14;36(7):434-9. doi: 10.1093/eurheartj/ehu455.
- Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Belohlavek J, Bohm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzalez-Medina A, Hagege AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan O, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.
- McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
- McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 dicembre 2009
Completamento primario (Effettivo)
1 maggio 2014
Completamento dello studio (Effettivo)
1 maggio 2014
Date di iscrizione allo studio
Primo inviato
16 dicembre 2009
Primo inviato che soddisfa i criteri di controllo qualità
17 dicembre 2009
Primo Inserito (Stima)
18 dicembre 2009
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
15 agosto 2016
Ultimo aggiornamento inviato che soddisfa i criteri QC
13 luglio 2016
Ultimo verificato
1 luglio 2016
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Malattie cardiache
- Malattia cardiovascolare
- Arresto cardiaco
- Meccanismi molecolari dell'azione farmacologica
- Agenti antipertensivi
- Inibitori enzimatici
- Inibitori della proteasi
- Antagonisti del recettore dell'angiotensina
- Inibitori dell'enzima di conversione dell'angiotensina
- Enalapril
- Combinazione di farmaci sacubitril e valsartan sodico idrato
Altri numeri di identificazione dello studio
- CLCZ696B2314
- 2009-015834-31
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su LCZ696 200 mg BID
-
Innovation Pharmaceuticals, Inc.CompletatoPsoriasi a placche stabile cronicaStati Uniti
-
Hoffmann-La RocheCompletatoEpatite cronica CStati Uniti, Porto Rico
-
CTI BioPharmaPPD Development, LPCompletatoInsufficienza epaticaStati Uniti
-
Hamamatsu UniversityCompletatoGastrite associata a Helicobacter PyloriGiappone
-
Novartis PharmaceuticalsCompletato
-
N-Gene Research Laboratories, Inc.Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum... e altri collaboratoriTerminatoDiabete mellitoStati Uniti, Germania, Ungheria
-
Acer Therapeutics Inc.CompletatoSintomi vasomotori postmenopausaliStati Uniti
-
MedPacto, Inc.TerminatoCarcinoma, polmone non a piccole celluleCorea, Repubblica di
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp &... e altri collaboratoriTerminato
-
AstraZenecaCompletatoMorbo di ParkinsonStati Uniti